Startseite Naturwissenschaften Antioxidant and antidiabetic potentials of methoxy-substituted Schiff bases using in vitro, in vivo, and molecular simulation approaches
Artikel Open Access

Antioxidant and antidiabetic potentials of methoxy-substituted Schiff bases using in vitro, in vivo, and molecular simulation approaches

  • Muhammad Kashif , Sumaira Naz , Muhammad Zahoor EMAIL logo , Syed Wadood Ali Shah , Jalal Uddin , Muhammad Esa , Haroon ur Rashid , Riaz Ullah und Amal Alotaibi
Veröffentlicht/Copyright: 23. September 2024
Artikel downloaden (PDF)
Open Chemistry
Aus der Zeitschrift Open Chemistry Band 22 Heft 1

Abstract

The current study attempted to synthesize methoxy-substituted Schiff’s bases, namely MK1 and MK2, and evaluate their antidiabetic effects using in vitro, in vivo, and molecular docking studies. Experimental animals (rat model) received the synthetic compounds, MK1 and MK2, orally in doses of 25 and 50 mg/kg body weight, respectively. When comparing compound MK2 at the tested doses to glibenclamide on day 28, the diabetic rats’ blood glucose levels were nearly normal (139.02 and 121.23 mg/dL at 25 and 50 mg/kg body weight doses). The IC50 for MK1 against α-glucosidase inhibitory potential was found to be 281.29 μg/mL, while for MK2, it is reported to be 204.69 μg/mL. Furthermore, the acute toxicity, lipid profile, and its effect on blood biochemical parameters were also examined. In addition, through in silico analysis, the binding of MK1 and MK2 was elucidated with α-glucosidase enzyme, showcasing its antidiabetic mechanism at molecular levels. The in silico studies also predicted the two compounds to be inactive toward the human hERGs cardiac potassium channel, which indicates no potential risk of cardiac toxicity. Overall, the toxicity predictions suggest that compounds MK1 and MK2 are non-toxic and non-carcinogenic.

Graphical abstract

Keywords: Schiff’s bases; antidiabetic potential; diabetes; glibenclamide

1 Introduction

Diabetes mellitus (DM), one of the metabolic illnesses, is characterized by a persistent increase in the level of blood glucose [1]. This is associated with the interruption of the metabolism of carbohydrates, proteins, and lipids. This variation in metabolism arises due to the low amount of insulin production from the pancreas or because the body does not use the insulin produced [2]. It ranks among the top ten causes of adult mortality, accounting for an estimated four million deaths globally in 2023 [3]. The biomarkers of diabetes include fasting blood sugar, hemoglobin A1c (HbA1c), insulin, β-cell function markers (e.g., HOMA-B), triglycerides (TG), lipid profile, and inflammatory biomarkers such as C-reactive protein [4,5]. These markers are essential for the diagnosis, monitoring, and management of diabetes, providing insights into blood sugar levels, insulin production, and overall metabolic health [6]. The most common types of DM include type 1 DM, type 2 DM, and gestational DM [7]. To effectively manage diabetes, oxidative stress and hyperglycemia must be addressed, as these conditions worsen diabetic complications. For the onset and progression of diabetes, oxidative stress, which is characterized by an excess of reactive oxygen species (ROS) generation and a deficiency of antioxidant defense, is essential [8]. By neutralizing ROS, antioxidants can reduce oxidative stress and prevent damage to biological components. While designing treatment plans to combat diabetes, combinations with antioxidant and antidiabetic properties are crucial [9].

The main groups of antidiabetic drugs are thiazolidinedione, dipeptidyl peptidyl 4 inhibitors, meglitinide, biguanides, sulfonylureas, and sodium-glucose cotransporter inhibitors [10]. However, the management of diabetes without experiencing negative side effects, even with the development of various synthetic oral medications, poses a major challenge [11]. Research on complementary medicines, synthesis, and natural therapies has expanded, and the search for more potent synthetic or semisynthetic compounds with fewer side effects has sparked a renewed wave of scientific interest in standard approaches [12]. Chemical compounds (imines) having a hydrocarbyl group on the nitrogen atom R2C = NR (R ≠ H) are known as Schiff bases. These Schiff bases can be interchangeable with azomethines. They are known as auxiliary ligands instead of reactive ligands because Schiff bases can modify the structure and reactivity of the transition metal ion in the center of the complex without undergoing any irreversible changes of their own [13]. To date, various pharmacological activities are documented, showcasing their role in many clinical applications, for instance, antibacterial [14], antifungal [15], herbicidal [16], anticancer [17], anthelmintic [18], antiviral [19], anti-HIV [20], antiprotozoal [21], anticonvulsant [22], and anti-inflammatory activity [23]. Because of their potential for functional modification, ease of synthesis, and diversity of structures, they are a dynamic option in medicinal chemistry. Methoxy substitution in Schiff bases is important because the electron-donating nature of the methoxy group influences their antioxidant potential [24]. Schiff bases of pioglitazone have shown improved antidiabetic and antioxidant properties and potential hints for dual therapeutics [25]. Likewise, Schiff bases of chitosan-quinoline have also significant increase in their antidiabetic and antioxidant potential [26]. Multiple studies have shown the antidiabetic potential of different types of Schiff bases [27]. Conversely, not much is known about the combined antidiabetic and antioxidant properties of methoxy-substituted Schiff bases [28]. The discovery of methoxy-substituted Schiff bases having both properties could lead to the development of new diabetes treatments. Molecular simulations can further provide detailed insights into the mechanism of action of these Schiff bases. A study comprising a comprehensive assessment of combined antioxidant and antidiabetic potential and their therapeutic relevance is necessary through in vitro, in vivo, and molecular docking analyses.

Keeping in view the immense potential of Schiff bases, in the present study, we have attempted to formulate methoxy Schiff bases and evaluated them for their antioxidant and antidiabetic activities. The antioxidant potential was evaluated in vitro, and their antidiabetic potential was evaluated in vivo by assessing their effect in the management of hyperglycemia in streptozocin (STZ)-induced diabetic rats. The synthesized compounds were designated as (E)-N-(4-methoxybenzylidene) benzenamine (MK1) and (E)-N-(4-methoxybenzylidene)-4-chlorobenzenamine (MK2), which were characterized by physicochemical characteristics as defined in the literature. These compounds were then used for testing their antidiabetic potential. The synthesized compounds and standard drug glibenclamide were orally administered to different groups of rats, including some groups with induced diabetic rats. Furthermore, the acute toxicity, lipid profile, and its effect on blood biochemical parameters were also examined. In addition, through in silico analysis, the binding of MK1 and MK2 was elucidated with α-glucosidase enzyme, showcasing its antidiabetic mechanism at molecular levels.

2 Materials and methods

2.1 Synthesis of (E)-N-(4-methoxybenzylidene) benzenamine (MK1) and (E)-N-(4-methoxybenzylidene)-4-chlorobenzenamine (MK2)

Schiff’s bases share the azomethine group, which has the generic formula RHC = N-R1, where R and R1 are variously substitutable cycloalkyl, heterocyclic, alkyl, or aryl groups [29]. These substances are sometimes referred to as azomethines, imines, or anils. Several studies have demonstrated the significant chemical and biological significance of a single pair of electrons in a sp2 hybridized orbital of the nitrogen atom in the azomethine group [30]. Schiff bases are generally good chelating agents due to their unique C═N group characteristic, relative ease of synthesis, and synthetic flexibility, particularly when a functional group such as −OH or −SH is close to the azomethine group so that it can combine with the metal ion to form a five- or six-membered ring [31]. Keeping in view the above nature, Schiff bases MK1 were synthesized by treating 4-methoxy benzaldehyde with aniline in the presence of sodium hydroxide at a temperature of 70°C in ethanol by reflux condensation for 5–12 h. For the synthesis of MK2, 4-methoxy benzaldehyde was treated with 4-chloroaniline in the presence of sodium hydroxide at a temperature of 70°C in ethanol by reflux condensation for 5–12 h [32,33].

2.2 In vitro antioxidant activity

Following the published protocol, the antioxidant potentials of the MK1 and MK2 were evaluated utilizing 2,2-diphenyl-1-picrylhydrazyl (DPPH) free radicals. To make a 0.04 mg/mL methanolic DPPH solution, 4 mg of DPPH was dissolved in 100 mL of methanol. Methanol was used to produce stock solutions of MK1 and MK2 samples, as well as standard solution (ascorbic acid). About 03 mL of methanolic DPPH was added to each concentration of stock solutions of samples and standard solution in different concentrations (50, 100, 150, and 200 μg/mL); the mixture was then incubated for 30 min at room temperature in a dark setting. A spectrophotometer (Shimadzu UV-1800, Kyoto, Japan) was used to detect the absorbance at 517 nm. An ascorbic acid standard was employed, while methanol served as the blank. A methanol auto-zero was developed for the UV spectrophotometer [34]. Standard tocopherol and its synthetic analogs (MK1 and MK2) were combined with the DPPH solution at various concentrations (µg/mL). The free radical scavenging activity was evaluated, and the IC50 values were determined.

2.3 α-Glucosidase inhibitory activity

The α-glucosidase inhibitory activity of the compounds (MK1 and MK2) was evaluated by completely mixing 20 μL of α-glucosidase (0.5 unit/mL), 120 μL of 0.1 M phosphate buffer at pH 6.9, and 10 μL of MK1 and MK2 at varying doses. Following that, the mixture was maintained at 37°C for 15 min in an incubator. The combination solution was then mixed with 20 μL of 5 mM p-nitrophenyl-α-d-glucopyranoside solution in 0.1 M phosphate buffer at pH 6.9. This made it possible for the enzymatic reaction to start. The absorbance was calculated at 405 nm. Following the measurement of α-glucosidase activity, the estimated IC50 values were determined [35].

2.4 In vivo studies

2.4.1 Animals

Rats weighing between 165 and 190 g were brought to the University of Malakand from the NIH Islamabad. Mice and rats were housed in a 25°C ± 2 environment with a light/dark (16/8) cycle. As stated in the literature, the process was conducted in accordance with the UK’s Animal Scientific Process Act (1986) [36].

2.4.2 Acute toxicity study

MK1 and MK2 rats (07 groups, each comprising four animals) were used to determine acute toxicity. Following the techniques of Hussain et al., with some modifications, the tests were carried out in two stages. During each phase, the experimental groups were given MK1 and MK2 orally at doses of 25 and 50 mg/kg body weight, respectively, whereas the control group received normal saline [34].

2.4.3 Administration of STZ

Before inducing diabetes, each animal was fasted for the entire night. Fresh STZ was produced in 0.1 mole of pH 4.5 citrate buffer. A single intraperitoneal dose of 50 mg/kg body weight of STZ was administered. When the animals’ blood glucose level exceeded 250 mg/dL, they were classified as diabetic [35].

2.4.4 Animals grouping and dosing

The animal groups constituted and doses given are summarized in Table 1.

Table 1

Animal’s grouping and dosing details

S. no. Group No. of rats Treatment Dose (mg) Route of drug administration
1 Control 04 Normal saline 10 PO
2 Diabetic 04 Normal saline 10 PO
3 Diabetic 04 MK-1 25 PO
4 Diabetic 04 MK-1 50 PO
5 Diabetic 04 MK-2 25 PO
6 Diabetic 04 MK-2 50 PO
7 Diabetic 04 Standard drug (glibenclamide) 5 PO

2.4.5 Blood profile

Assessment of glucose level and body weight was carried out on the 29th day of the experimental cycle. Animals were sacrificed with the help of isoflurane given through the cardiac puncture for the collection of blood samples for the evaluation of ex-vivo parameters.

2.4.6 Assessment of serum profile

Many biochemical parameters, for example, low-density lipoprotein (LDL), high-density lipoprotein (HDL), total cholesterol (TC), alkaline phosphatase (ALP), TG, and insulin level were determined.

2.5 In silico studies

Molecular docking is a computational technique used to understand the complex structures formed by the interaction of multiple molecules. Its main goal is to predict the three-dimensional (3D) configuration of a ligand within the binding site of a target receptor protein. This method plays a crucial role in drug discovery and has quickly become an essential tool in modern drug design [37]. For our docking study, we selected the α-glucosidase enzyme as a receptor. We used the crystal structure of sugar beet α-glucosidase (PDB: 3W37), which was retrieved from the Protein Data Bank (https://www.rcbs.org). The protein was prepared using Molecular Operating Environment (MOE) software 2022 [38]. Initially, water molecules and attached ligands were removed using the MOE SEQ window. Missing amino acid residues were identified and repaired using Modeler software [39]. Any residual structural deficiencies were adjusted through the MOE structural preparation window. The 3D structures were protonated, and partial charges were assigned by the Gasteiger (PEOE) forcefield. The energy of the protein was minimized using the Amber14 forcefield precisely designed for amino acids and proteins. Active sites were recognized by applying the site finder tool integrated into MOE software. After preparation, the protein was obtained in a ready-to-dock format. Similarly, using ChemDraw software, structures of methoxy-substituted Schiff bases (MK1 and MK2) were drawn and stored in mol format [40]. Later, MOE was used to convert these structures to PDB format. They underwent an energy minimization process prior to molecular docking analysis, and the MOE then transformed them into sdf format.

Part of the drug development process involves predicting a possible drug candidate’s physicochemical, pharmacological, toxicological, and pharmacokinetic characteristics. A compound’s druggability can be estimated using these factors. There are predictions regarding the possible drug candidates’ toxicity, water solubility, lipophilicity, compliance with Lipinski’s criteria, topological polar surface area (TPSA), and blood–brain barrier (BBB) penetration [41]. In silico models were utilized to predict the toxicity and absorption, distribution, metabolism, and excretion (ADME) of the chosen methoxy-substituted Schiff bases (MK1 and MK2). The SwissADME service predicted pharmacokinetics, drug-likeness (Lipinski’s rules), physicochemical characteristics, lipophilicity (log Po/w), water solubility (log S), and pharmacokinetics [42]. Toxicity was predicted online by the pkCSM [43] and ProTox 3.0 online servers [44].

3 Results and discussion

3.1 Properties and spectral details of the synthesized compounds

In order to make Schiff’s bases MK1, 4-methoxy benzaldehyde was treated with aniline in the presence of sodium hydroxide at a temperature of 70°C in ethanol by reflux condensation for 05–12 h. In order to produce MK2, 4-methoxy benzaldehyde was reflux-condensed for 05–12 h at a temperature of 70°C in ethanol with the presence of 4-chloroaniline. The synthesized compounds MK1 and MK2 were obtained with a good yield and purity. Their physical properties, such as appearance, solubility, melting point, and r.f., are detailed in Table 2. The spectral data for MK1 and MK2 match previous literature reports, confirming their identity. The reported 1H NMR (CDCl3, 400 MHz) for MK1 is 8.37 (s, 1H, N═CH), 7.72 (s, 2H, Ar-H), 7.23–7.70 (m, 7H, Ar-H), 3.84 (s, 3H) and MK2 is 8.35 (s, 1H, CH═N), 7.85–7.83 (d, J = 8.8 Hz, 2H, Ar-H), 7.35–7.33 (d, J = 8.8 Hz, 2H, Ar-H), 7.14–7.12 (d, J = 8.7 Hz, 2H, Ar-H), 7.00–6.97 (d, J = 8.8 Hz, 2H, Ar-H), 3.88 (s, 3H, OCH3) [45,46]. In the literature, various methods are followed to synthesize Schiff bases; for instance, the synthesis of two Schiff bases, 2-[(2-hydroxynaphthalen-1-ylmethylene)-amino], has been described by Neelofar et al. They reacted 2-hydroxy-1-naphthaldehyde and l-histidine combine to produce 3-(1H-imidazol-4-yl)-propionic acid (HNLH), and 4-[(2-hydroxynaphthalen-1-ylmethylene)-amino] N-(4methyl-pyrimidin-2-yl)-benzenesulfonamide (HNSM) is produced when 2-hydroxy-1-naphthaldehyde and sulfamethazine condensed [47]. The Schiff bases SP-5 (benzylidene aniline) and SP-18 (benzylidene urea) were produced by Wahab et al. by condensation of benzaldehyde with aniline and urea in the presence of natural acid that was derived from tamarind and lemon [48]. The condensation reaction of chitosan/O-CMC with nitro- and chloro-substituted salicyl aldehydes has been reported to yield six distinct chitosan-based Schiff bases [49]. Another study attempted to synthesize Schiff base (cobalt(iii) chelate with tridentate azomethine ligand containing a benzimidazole moiety) by the reaction of o-aminophenol with 2-acetylbenzimidazole and used to prepare the cobalt(iii) complex [CoL2]2(ClO4)2⋅3H2O (i) [50].

Table 2

Physical parameters of the synthesized compounds

Comp Structure Mol. formula Appearance Molecular weight. Yield% Solubility m.p. (°C) r.f. Ref.
MK1
(E)-N-(4-methoxybenzylidene) benzenamine		 C14H13NO Yellowish white solid 211.26 768.1 Chloroform, methanol 64–68 0.57 [51,52]
MK2
(E)-N-(4-methoxybenzylidene)-4-chlorobenzenamine		 C14H12ClNO White solid 245.71 74.2 Chloroform, methanol 119–121 0.66 [53]

3.2 Antioxidant activity

The antioxidant potentials of MK1 and MK2 were assessed through the DPPH scavenging assay. The IC50 for MK1 against DPPH potential was found to be 131.67 μg/mL, while for MK2, it is reported to be 112.04 μg/mL (Table 3). The inhibitory activity of tocopherol in terms of IC50 is 15.92 μg/mL. MK2 indicates higher antioxidant activity compared to MK1. When the relevant literature is examined, it can be observed that Schiff bases exhibit antioxidant potentials. For example, a study evaluated the antioxidant activity of several resveratrol analogs, such as p-(N,N-dimethyl)aminobenzylidene-2-aminothiophenol, p-nitrobenzylidene-2-aminothiophenol, and 4′-hydroxyphenyl-benzo[d]thiazole [54]. These analogs were synthesized, characterized, and their antioxidant activity was assessed. It has been found that chitosan derivatives with Schiff bases have better antifungal and antioxidant properties. Many chitosan derivatives containing Schiff bases were produced in a recent study. This study assessed the antioxidant properties of chloracetyl chitosan oligosaccharide derivatives grafted with pyridine-4-aldehyde Schiff bases against O2˙– and the DPPH˙ radical by performing structural characterization [55]. A study employed various techniques, such as the FRAP and CUPRAC reduction methods and the ABTS and DPPH radical scavenging methods, to demonstrate the effective antioxidant activity of the Co2+ and Fe2+ complexes of Schiff bases [56]. Profound antioxidant properties were also demonstrated by certain Schiff base ligands ((E)-6-methyl-2-(2,3,4-trimethoxybenzylideneamino)-4,5,6,7-tetrahydrobenzo[b]-thiophene-3-carbonitrile) and associated Co2+ and Pd2+ complexes [57].

Table 3

Antioxidant potentials of the synthesized compounds in terms of their IC50 values

Sample DPPH IC50 (μg/mL)
MK1 131.67
MK2 112.04
Tocopherol 15.92

3.3 Glucosidase inhibitory activity

The antidiabetic potentials of MK1 and MK2 are summarized in Table 4. The IC50 for MK1 against α-glucosidase inhibitory potential was found to be 281.29 μg/mL, while for MK2, it is reported to be 204.69 μg/mL. The inhibitory activity of α-glucosidase for acarbose in terms of IC50 is 46.81 μg/mL. Studies have shown that the Schiff base’s structural backbone determines the extent to which substitution inhibits α-glucosidase. In comparison to their unsubstituted derivatives, the enzymatic inhibition improved to varying degrees upon substitution of the Schiff bases by either the hydroxy or nitro group [58]. The hydroxylation reaction is most likely the cause of the extremely low IC50 values that the o-hydroxyl derivatives (2, 5, and 8) showed when it came to the inhibition of α-amylase and α-glucosidase. Comparing the p-nitro Schiff bases (7–9) to their unsubstituted counterparts, the inhibitory actions of the former demonstrated increased activity against the digestive enzymes, primarily due to glycosylation of the functional unit. The only deviation was Schiff base (1)’s decreased inhibitory efficacy against α-amylase, which may have resulted from its stereochemical arrangement [59]. Due to the presence of a sulfonic acid moiety that altered the enzymes’ ideal operating pH, Schiff bases (7–9) exhibited the least inhibitory action (IC50 values 4.20 × 102 ± 0.34 to 9.61 × 102 ± 0.84), as reported in the study by Ahmed et al. [60]. The 89.8% suppression of α-amylase and the 88.81% inhibition of hemoglobin in the niosomal formulation’s in vitro antidiabetic potential were both significantly higher than the levels attained with acarbose, indicating antidiabetic effectiveness. Protein structural changes in hemoglobin and α-amylase were discovered by interaction binding tests between phytoniosomes and extract. Based on the polyphenol analysis in the study by Imtiaz et al., Tradescantia pallida leave extract and niosomes contained well-established antidiabetic active substances [61].

Table 4

Anti-glucosidase potentials of the synthesized compounds in terms of their IC50 values

Sample Glucosidase IC50 (μg/mL)
MK1 281.23
MK2 204.69
Acarbose 46.81

3.4 In vivo antidiabetic studies

3.4.1 Effect on the blood glucose level

In the in vivo experiments, 25 and 50 mg/kg body weight of the complexes were utilized, which was 1/10th of the maximal acceptable dose according to OCED guidelines, since the acute toxicity research results showed that 500 mg/kg body weight was classified as non-toxic with no discomfort. Table 5 makes it clear that, immediately following 30, 60, 90, and 120 min after the compounds in tested quantities were administered, there is no apparent distinction between the blood glucose levels of the treatment group and the normal control group.

Table 5

Blood glucose levels (mg/dL) of rats treated with various drug agents at different concentrations

Days NC DC MK1 (25 mg) MK1 (50 mg) MK2 (25 mg) MK2 (50 mg) STD
Day 1 Mean 103.32 459.15 463.67 459.98 471.05 464.33 460.48
SEM 2.18 7.19 7.32 6.61 5.84 7.00 6.31
Day 7 Mean 98.62 477.13 406.37 365.83 379.15 359.95 328.42
SEM 2.57 6.20 4.24 5.23 5.33 4.80 4.41
Day 14 Mean 102.62 469.05 323.77 291.47 298.17 294.93 265.25
SEM 2.36 6.26 5.32 4.06 4.04 3.53 3.47
Day 21 Mean 103.83 461.57 236.65 201.18 202.70 177.53 156.12
SEM 3.60 6.46 3.65 3.16 3.65 2.13 2.99
Day 28 Mean 100.55 454.63 175.47 146.82 139.02 121.23 111.67
SEM 2.09 6.34 4.24 3.47 4.76 4.20 2.82

After oral delivery, the glucose level in the MK1- and MK2-treated groups appeared to be lower than in the control group. The blood glucose levels of group 3 and 4 animals were recorded as 463.67 and 459.98 mg/dL after 07 days of receiving a dosage of MK1 at a rate of 25 and 50 mg/kg body weight (bw). A notable drop in the glucose level was noted on day 14 (323.7 and 291.47 mg/dL), 21 (236.65, 201.18 mg/dL), and 28 (175.47 and 146.82 mg/dL). The total drop in the blood glucose level by MK1 (25 and 50 mg/kg) from day 01 to 28 was 288.2 and 313.16 mg/dL, respectively. Similarly, the blood glucose levels of group 05 and 06 animals receiving MK2 at doses of 25 and 50 mg/kg bw were recorded for 28 days. On days 7 and 14, the blood glucose level was recorded as 379.15 and 298.17 mg/dL (receiving MK2 at a dose of 25 mg/kg), while 359.95 and 294.93 mg/dL (receiving MK2 at a dose of 25 mg/kg), respectively. The total drop in blood glucose level from day 01 to 28 was 332.03 (receiving MK2 at a dose of 25 mg/kg) and 343.1 mg/dL (receiving MK2 at a dose of 50 mg/kg). Group 7 received glibenclamide (standard drug) at a dosage of 5 mg/kg bw, and blood glucose level dropped to 328.42 mg/dL after 07 days. After 14 and 21 days, blood glucose level was lowered to 265.25 and 156.12 mg/dL, with a total reduction of 304.36 mg/dL after 21 days. After the initiation of the experiment, the blood glucose level dropped to 11.67 mg/dL, indicating a total reduction of 348.81 mg/dL since the administration of the standard drug.

Overall, glibenclamide and MK2 have shown the best activity among these compound-based blood glucose lowering effects in tested models with a total reduction of 332.03 (receiving MK2 at a dose of 25 mg/kg), 343.1 mg/dL (receiving MK2 at a dose of 50 mg/kg), and 348.81 mg/dL (receiving glibenclamide as standard drug).

3.4.2 Effects on body weight

Table 6 presents the impact of diabetes on body mass and the contribution of chemical compounds to its recovery. The animals in the diabetic group showed a notable reduction in weight. However, in comparison to the standard group, the MK1 and MK2 sets have significantly helped the body recover from the weight loss associated with diabetic conditions. After 14 days of analysis, the diabetic group’s weight was 180.65 g, indicating a weight loss due to STZ activity, compared to 179.72 g for the control group. At the first day, the weight of the JA1-cured animals was set at 175.43 and 176.42 g, with quantities of 25 and 50 mg/kg bw; these weights were rather close to the animals in the normal control group. MK2 has regularized the body weight to 177.98 and 175.42 g for the experimental group. The body weight of 176.08 g was normalized with glibenclamide, a standard antidiabetic drug, prescribed at a dose of 5 mg/kg bw.

Table 6

Effect of various drug agents at different concentrations on body weight of STZ-induced diabetic rats

Days NC DC MK1 (25 mg) MK1 (50 mg) MK2 (25 mg) MK2 (50 mg) STD
Day 1 Mean 179.72 180.65 175.43 176.42 177.98 175.42 176.08
SEM 2.56 2.02 3.78 2.13 2.94 1.92 2.91
Day 28 Mean 174.72 149.50 165.15 164.98 167.32 168.13 170.53
SEM 2.62 2.88 3.37 2.41 3.61 2.69 2.16

According to the results obtained on the 28th day, the animals in the normal group weighed an average of 174.72 g, while the animals in the diabetic group weighed an average of 149.50 g. This indicates that diabetes has caused a significant reduction in body weight, which has been controlled by the MK2, MK1, and standard drugs. Similarly, MK2 at specified doses has increased the animals’ weight by roughly 167.32 and 168.13 g, as noted for groups 5 and 6. Group 7 (glibenclamide group) weights were recorded as 170.53 g. Following dosages of 25 and 50 mg/kg body weight daily for 28 days (165.15 and 164.98 g, respectively), MK1 contributed to an increase in the weight of group 3 and 4 animals. Similarly, MK2 at specified doses has increased the animals’ weight by roughly 167.32 and 168.13 g, as noted for groups 5 and 6. Group 7 (glibenclamide group) weights were recorded as 170.53 g.

3.4.3 Antihyperlipidemic effects

Table 7 lists the lipid profile of the STZ-induced diabetic animals after receiving various drug agents at different concentrations. TG, cholesterol, and LDL levels in the animals with diabetes are comparatively high compared to the corresponding normal group; however, there is a noticeable decrease in HDL in the diabetic group. MK1, MK2, and glibenclamide (standard drug) have normalized the levels of TG, cholesterol, and LDL and HDL. In STZ diabetic rats, MK1 and MK2 at doses of 25 and 50 mg/kg bw reduced the levels of CH, TG, and LDL, while at the same time, they improved the levels of HDL at the specified doses. The distinct effects on lipid profile factors have been pronounced per the given facts.

Table 7

Effects of various drug agents at different concentrations on the lipid profile of STZ-induced diabetic rats

Biomarker NC DC MK1 (25 mg) MK1 (50 mg) MK2 (25 mg) MK2 (50 mg) STD
HDL Mean 38.40 118.33 85.62 76.53 66.39 61.12 47.29
SEM 1.77 5.87 4.79 4.20 2.94 3.69 4.00
LDL Mean 66.22 37.23 44.04 49.33 47.58 48.89 58.19
SEM 3.95 2.25 2.22 2.51 2.35 2.92 3.78
TG Mean 105.30 215.92 145.15 129.01 130.05 118.15 109.73
SEM 3.31 7.80 3.67 5.75 5.23 4.12 4.07
CH Mean 59.25 205.72 102.46 91.94 87.21 74.42 64.28
SEM 2.64 8.23 2.75 3.27 3.06 2.52 4.64
ALP Mean 115.45 237.03 146.65 132.78 145.92 134.49 123.82
SEM 5.11 11.15 4.79 3.79 3.37 2.49 5.53
3.4.3.1 Effects on blood cholesterol level

Blood cholesterol levels were reported to be 59.25 mg/dL in the control group and 205.72 mg/dL in the diabetes group (Table 7). The lower values experienced in distinction for the diabetic group would demonstrate the enhancing effects of the compounds, according to the groups given the compounds at the same time and also experiencing diabetes. Blood cholesterol levels were dropped to 102.46 mg/dL in group 3 after receiving MK1 treatment at a dose of 20 mg/kg bw, while group 4 received a higher dose of 50 mg/kg bw, which elevated blood cholesterol levels to 91.94 mg/dL. While the standard group’s level was recorded at 64.28 mg/dL, MK2 in groups 5 and 6 reduced the CH level to 87.21 and 74.42 mg/dL at the tested levels. It was noted that MK2 had demonstrated notable activities among the validated compounds based on the values of lowering cholesterol levels in STZ-induced diabetic rat models.

3.4.3.2 Effects on LDL

In both the normal control and diabetic control groups, the LDL level rises with diabetes and is significantly higher than expected (66.22 mg/dL in group 1 and 37.23 mg/dL in group 2, Table 7). The hypolipidemic effects of MK1 therapy have been demonstrated at 44.04 md/dL and 49.33 mg/dL in groups 3 and 4, respectively, at doses of 25 and 50 mg/kg bw. MK2 nearly decreased in identical amounts, with values in group 5 and 6 animals being 47.58 mg/dL and 48.89 mg/dL, respectively. The level for the glibenclamide-treated group was found to be 58.19 mg/dL. MK2 appeared as the most potent compound among all of the tested drugs.

3.4.3.3 Effects on TG

Excessive intake of oil and DM are associated with elevated TG levels. At this point, Table 7 makes it clear that the animal in the normal control group has a TG level of 105.30 mg/dL, which has increased almost twofold in advance to the onset of diabetes (215.92 mg/dL). Following treatment with MK1 at dosages of 25 and 50 mg/kg body weight, groups 3 and 4 experienced an increase in TG levels to 145.15 and 129.01 mg/dL, respectively. The TG levels in Groups 5 and 6 increased to 130.05 and 118.15 mg/dL after receiving the same amounts of MK2. Glibenclamide-treated group (group 7) experienced a notable decrease in TG levels with a value of 109.73 mg/dL.

3.4.3.4 Effects on HDL

Diabetes typically causes a reduction in HDL levels, which are utilized as a diagnosis indicator. Table 7 shows that the HDL level in the normal control group is 38.40 mg/dL; however, in group 2 animals, the STZ booster caused the HDL level to drop to 118.33 mg/dL. Following treatment, the STZ diabetic rats in groups 3 and 4 showed improvement in this level, reaching 85.62 and 76.53 mg/dL, respectively. MK1 only had a small impact on improving the abnormal parameters. The HDL levels of the MK2-treated animals were increased to 66.39 and 61.12 mg/dL, respectively, as observed for the animals in groups 5 and 6. After receiving glibenclamide, the HDL level of the group 7 animals reached 47.29 mg/dL.

3.5 Effect on the level of HBA1c

According to Table 8, the HBA1c value for the normal control group was 4.54; however, the diabetes control group’s value was 14.76. MK1 at doses of 25 and 50 mg was administered to groups 3 and 4, respectively. For 25 mg, the reported HBA1c level was 9.67 mmol/mol, whereas for 50 mg, it was 7.92 mmol/mol. Likewise, following treatment of groups 5 and 6 with MK2 at doses of 25 and 50 mg, respectively, the HBA1c levels were recorded as 7.98 and 7.51, and 5.07 mmol/mol for the standard. Lastly, for group 7 receiving the standard drug, the HBA1c levels were recorded as 5.07 mmol/mol.

Table 8

Effects of various drug agents at different concentrations on the HBA1c in STZ diabetic rats

Days NC DC MK1 (25 mg) MK1 (50 mg) MK2 (25 mg) MK2 (50 mg) STD
HBA1c Mean 4.54 14.76 9.67 7.92 7.98 7.51 5.07
SEM 0.22 1.44 0.45 0.41 0.53 0.42 0.18

3.6 Discussion on the key results obtained from in vivo studies

In this study, we investigated the antidiabetic effects of the administration of the two compounds MK1 and MK2 on glucose levels, body weight, lipid profile, and HBA1c homeostasis in the presence and absence of drug intervention in the STZ pre-diabetic rat model. Compounds MK1 and MK2 were given to diabetic rats at 25 and 50 mg/kg body weight in the in vivo antidiabetic trials. Over the course of 28 days, the rats’ blood glucose levels significantly decreased. MK2 demonstrated a total reduction of 343.1 mg/dL, especially at 50 mg/kg, which was almost identical to the reduction of 348.81 mg/dL seen with the standard drug glibenclamide. Additionally, the compounds improved diabetes-induced body weight loss; groups treated with MK2 showed the strongest recovery. Besides, MK1 and MK2 showed strong antihyperlipidemic effects by considerably lowering cholesterol, TG, and LDL levels while raising HDL levels. Additionally, both substances successfully reduced HbA1c levels, demonstrating their general effectiveness in the management of diabetes and related metabolic disorders. Elevated HbAc1 levels are a long-term marker of pre-diabetes, a disease that frequently occurs before type 2 diabetes [62]. The current study supports previous research showing that, when compared to a conventional diet, the consumption of Schiff bases significantly decreased the incidence of diabetes and calorie intake in rats. The reduction in blood glucose and body fat remained subsequently maintained [25,63]. Reduced calorie intake and potential antidiabetic effect in mice models can be attributed to the observed decrease in body weight [64]. Another study found that administering the ruthenium complex in conjunction with dietary modification decreased calorie intake, indicating that this complex may have an activity via improving caloric intake [65]. Additionally, research indicates that metformin, a frequently prescribed drug for pre-diabetes, can lower calorie intake in obese pre-diabetic individuals, hence restoring their body weight. These were further supported by the findings of a recent study published in the literature [66]. In comparison to normal healthy mice, the diabetic control mice had remarkably higher levels of TC, TG, HDL, LDL, and VLDL, according to the biochemical examination of lipids. However, the treated groups exhibited reduced damage, particularly those treated with MK2, whose profile was comparable to that of the standard treated group. Insulin stimulates the lipoprotein–lipase enzyme, which facilitates the breakdown of TG into glycerol and fatty acids, consequently initiating the metabolism of lipids [25,63]. These fats are essential because they give the body energy and serve as a transporter for stored energy. Hypertriglyceridemia in diabetes is caused by the inactivation of the lipoprotein–lipase enzyme by insulin shortage or resistance. The movement of cholesterol from the liver to other tissues that may develop coronary heart disease is the cause of elevated LDL. Although HDL serves as a valuable lipoprotein and excellent cholesterol, it protects atherosclerosis by delivering endogenous cholesterol and cholesterol esters to the liver and steroidogenic cells. When compared to extract- and acarbose-treated mice, the study by Imtiaz et al. showed that niosome-treated alloxan-induced diabetic mice had normal lipid values [67].

3.7 Molecular docking studies

In the present study, the inhibition potential of the synthesized Schiff bases against α-amylase and α-glucosidase was evaluated through molecular docking to elucidate their mechanism of action and role in controlling hyperglycemia and management of diabetes. Compound MK1 exhibited a docking score of −5.22 kcal/mol and formed H–pi and pi–H interactions with residues TRP329 and ALA234, respectively, with 3W37. The two-dimensional (2D) and 3D interactions of MK1-3W37 are shown in Figures 1 and 2.

Figure 1 (a) 2D and (b) 3D interactions of MK1-3W37.
Figure 1

(a) 2D and (b) 3D interactions of MK1-3W37.

Figure 2 (a) 2D and (b) 3D interactions of MK2-3W37.
Figure 2

(a) 2D and (b) 3D interactions of MK2-3W37.

The digestive enzymes that catalyze the breakdown of carbohydrates into blood sugar can be identified as α-amylase and α-glucosidase. The small intestine’s brush surface contains the enzyme α-glucosidase, which breaks down polysaccharides, whereas the salivary gland and pancreas release α-amylase, which converts starch and oligosaccharides into sugar [68]. By reducing the metabolism of carbohydrates, these enzymes’ inhibition plays an essential role in regulating blood glucose levels. Nowadays, a number of antidiabetic medications, including acarbose, voglibose, and miglitol, are used in clinical practice. These medications work by decreasing the activity of the α-glucosidase enzyme, which interferes with the metabolism of carbohydrates and lowers the risk of postprandial hyperglycemia and hyperinsulinemia [69]. A recently reported study unveiled the presence of syringic acid, p-coumaric acid, morin, and catechin in Tradescantia pallia leaves and confirmed that these compounds exhibited significant antidiabetic potential by inhibiting α-amylase enzyme and non-enzymatic glycosylation of hemoglobin [70]. In several research attempts, the in vitro antidiabetic potential of the compounds is assessed using α-amylase and non-enzymatic glycosylation of hemoglobin protein assays. A mechanistic insight into interactions between the chemical compound, human α-amylase, and hemoglobin protein is scrutinized by employing the molecular docking method [71]. Additionally, hyperglycemia can cause non-enzymatic glycosylation of proteins, particularly hemoglobin, which is a diagnostic marker for type 2 diabetes. To control hyperglycemia associated with diabetes, researchers aim to inhibit α-amylase. A recent study by Imtiaz et al. attempted to assess the antidiabetic activity of phenolic compounds obtained from T. pallida through α-amylase enzyme inhibition assay. According to the study findings, syringic acid and p-coumaric acid exhibited 61 and 45% inhibition of α-amylase at 1 mg/mL, while morin and catechin showed 73.59 and 67.52% inhibition of α-amylase at 750 µg/mL [72]. By offering comprehensive insights into receptor–ligand interactions, energy compatibility, and binding modalities, molecular docking facilitates the identification of promising compounds and simplifies the drug development process [70].

Compound MK2 exhibited a binding energy of −5.73 kcal/mol and formed two interactions with 3W37. A pi–cation interaction was established between the aromatic ring of compound MK2 and the cation of residue ARG670 of the 3W37 enzyme. Similarly, a pi–H interaction was established between the second aromatic ring of compound MK2 and the hydrogen atom of the residue GLU792 of the 3W37 enzyme. The 2D and 3D interactions of MK2-3W37 are shown in Figure 2.

By forming interactions in the vicinity of the active site of the α-glucosidase enzyme, compounds MK1 and MK2 can hinder its normal function. The docking results suggest that the two compounds can act as possible α-glucosidase inhibitors by suppressing the absorption of carbohydrates from the small intestine (Table 9). Consequently, they might be assessed as antihyperglycemic drugs, which could reduce blood sugar by delaying the breakdown and absorption of complex carbohydrates [73].

Table 9

Binding scores, RMSD values, receptor interactions, distances, and energies of methoxy-substituted Schiff bases (MK1 and MK2)

Ligand Docking score (kcal/mol) RMSD Receptor interaction Distance (Å) E (kcal/mol)
MK1 −5.22 1.29 TRP329/H–pi 3.80 −1.3
ALA234/pi–H 4.22 −0.5
MK2 −5.73 2.04 ARG670/pi–cation 3.54 −0.8
GLU792/pi–H 4.09 −0.9

The predicted ADME results indicate that the two compounds obey Lipinski’s rule of 5, as they did not show any violation of the rule. A molecule with a molecular mass less than 500 Da, no more than five hydrogen bond donors, no more than ten hydrogen bond acceptors, and a log P (lipophilicity measure) not greater than 5 are the requirements for an orally active drug candidate according to Lipinski’s rule of 5 [74]. The TPSA values of both compounds were recorded to be in the optimum range (21.59 Å2). According to the Veber rule, the optimal range of TPSA values is 0–140 Å2 [75]. A key step in drug absorption is the breakdown of the capsule or tablet and its subsequent dissolution. Poor aqueous solubility is unfavorable to decent and thorough oral absorption. Therefore, the initial determination of water solubility is of great significance in drug discovery [76]. The predicted water solubility of a potential drug candidate is given as the logarithm of the molar concentration (log mol/L) and is denoted by log S. Drugs with aqueous solubility values in the range of −4 to 0.5 log mol/L are regarded as soluble [43]. In this context, the in silico results also confirmed favorable log S values of −3.26 and −3.80 for MK1 and MK2, respectively. Moreover, the gastrointestinal absorption of both compounds was predicted to be high.

The toxicity results indicate that both compounds were found to be inactive against hepatotoxicity, carcinogenicity, cardiotoxicity, nephrotoxicity, respiratory toxicity, nutritional toxicity, and clinical toxicity. However, both compounds were predicted to be active for skin sensitization. The main cause of drug cancellation in drug discovery is cardiac toxicity. Compounds that bind to the cardiac potassium channel encrypted by the human ether-a-go-go-related gene (hERG) are commonly known to cause cardiotoxicity. This can result in an extended QT syndrome, which can lead to fatal ventricular arrhythmias and sudden death [76]. The in silico studies also predicted the two compounds to be inactive toward the human hERGs cardiac potassium channel, which indicates no potential risk of cardiac toxicity. The median lethal dose weight (LD50) was predicted to be 500 mg kg−1 for both compounds, categorizing them as class 4 toxic. Overall, the toxicity predictions suggest that compounds MK1 and MK2 are non-carcinogenic and non-toxic. The Bioavailability Radar of the compounds MK1 and MK2 is presented in Figure 3 for a swift assessment of drug-likeness. The overall ADME and toxicity results are provided in Table 10.

Figure 3 Radar for bioavailability of compounds (a) MK1 and (b) MK2. The pink area denotes the ideal range for each property: size: TPSA between 0.00 and 140 Å2 (based on the Veber rule), flexibility: no more than nine rotatable bonds, solubility: log S not higher than 6, lipophilicity: XLOGP3 between −0.7 and +5.0, saturation: fraction of carbons in the sp3 hybridization not less than 0.25.
Figure 3

Radar for bioavailability of compounds (a) MK1 and (b) MK2. The pink area denotes the ideal range for each property: size: TPSA between 0.00 and 140 Å2 (based on the Veber rule), flexibility: no more than nine rotatable bonds, solubility: log S not higher than 6, lipophilicity: XLOGP3 between −0.7 and +5.0, saturation: fraction of carbons in the sp3 hybridization not less than 0.25.

Table 10

ADME and toxicity predictions of compounds MK1 and MK2

Properties MK1 MK2
Molecular weight (Da) 211.26 225.29
Number of rotatable bonds 3 3
Number of hydrogen bond donors 0 0
Number of hydrogen bond acceptors 2 2
TPSA (Å2) 21.59 21.59
Lipophilicity: XLOGP3 (log Po/w) 2.79 3.56
Lipophilicity: consensus (log Po/w) 3.15 3.58
Gastrointestinal absorption High High
Water solubility (log S) (calculated with the ESOL model) −3.26 −3.80
BBB permeation Yes Yes
Lipinski’s rules (violations) 0 0
Clinical toxicity No No
Predicted median lethal dose (LD50) (mg/kg) 500 500
Max. tolerated dose in humans (Log mg/kg/day) 0.799 0.761
hERG I inhibitor No No
hERG II inhibitor No No
Carcinogenicity No No
Cardiotoxicity No No
Hepatotoxicity No No
Nephrotoxicity No No
Nutritional toxicity No No
Respiratory toxicity No No
Skin sensitization Yes Yes

4 Conclusions

According to the study findings, the chemical compounds MK1 and MK2 significantly reduce blood glucose levels, improve body weight, and restore normal lipid profiles in STZ-induced diabetic rats. For instance, MK2 showed significant antihyperlipidemic advantages in addition to strong glucose-lowering effects that were almost on the scale with the standard drug glibenclamide. MK2 demonstrated a total glucose reduction of 343.1 mg/dL, especially at 50 mg/kg, which was almost identical to the reduction of 348.81 mg/dL seen with the standard drug glibenclamide. Additionally, the compound improved diabetes-induced body weight loss; groups treated with MK2 showed the strongest recovery. The compounds exhibited a significant decrease in HbA1c levels, suggesting their potential for long-term diabetes control. In silico analysis confirmed the binding of MK1 and MK2 with α-glucosidase enzyme, showcasing its antidiabetic mechanism at molecular levels. The in silico studies also predicted that the resulting compounds possess no potential risk of cardiac toxicity. These results imply that MK1 and MK2 may be good options for the development of novel antidiabetic medications. Accordingly, MK-2 might be made available for in vivo evaluation in multiple animal models in order to extend and validate its potential use as a diabetic drug for humans in the near future.

Acknowledgements

The authors wish to thank Princess Nourah bint Abdulrahman University Researchers Supporting Project (number PNURSP2024R33), Princess Nourah bint Abdulrahman University, Riyadh, Saudi Arabia, for the financial support.

  1. Funding information: This work was supported by the Researchers Supporting Project (number PNURSP2024R33), Princess Nourah bint Abdulrahman University, Riyadh, Saudi Arabia.

  2. Author contributions: MK, SWAS, JU, ME, and SZ performed the experiments; MZ, SZ, RU, AA, and HUR conceptualized the study and devised the experimental design; MK, JU, SZ, RU, AA, and MZ wrote the initial draft of the paper. All authors have read the paper and have given consent to publish the data in this journal.

  3. Conflict of interest: The authors of this article have no conflict of interest.

  4. Ethical approval: The conducted research is not related to either human or animals use.

  5. Data availability statement: The datasets generated during and/or analyzed during the current study are available from the corresponding author on reasonable request.

References

[1] Alam S, Hasan MK, Neaz S, Hussain N, Hossain MF, Rahman T. Diabetes Mellitus: insights from epidemiology, biochemistry, risk factors, diagnosis, complications and comprehensive management. Diabetes. 2021;2:36–50.10.3390/diabetology2020004Suche in Google Scholar

[2] Mohajan D, Mohajan HK. Hyperglycaemia among diabetes patients: a preventive approach. Innov Sci Technol. 2023;2:27–33.10.56397/IST.2023.11.05Suche in Google Scholar

[3] Li X, Liu R, Chen Y, Han Y, Wang Q, Xu Y, et al. Patterns and trends in mortality associated with and due to diabetes mellitus in a transitioning region with 3.17 million people: Observational Study. JMIR Pub Health Surv. 2023;9:e43687.10.2196/43687Suche in Google Scholar PubMed PubMed Central

[4] Biradar SB, Desai AS, Kashinakunti SV, Rangappa M, Kallaganad GS, Devaranavadagi B. Correlation between glycemic control markers and lipid profile in type 2 diabetes mellitus and impaired glucose tolerance. Int J Adv Med. 2018;5:832–7.10.18203/2349-3933.ijam20182489Suche in Google Scholar

[5] Zhang H, Zuo JJ, Dong SS, Lan Y, Wu CW, Mao GY, et al. Identification of potential serum metabolic biomarkers of diabetic kidney disease: a widely targeted metabolomics study. J Diab Res. 2020;1:3049098.10.1155/2020/3049098Suche in Google Scholar PubMed PubMed Central

[6] Ortiz-Martínez M, González-González M, Martagón AJ, Hlavinka V, Willson RC, Rito-Palomares M. Recent developments in biomarkers for diagnosis and screening of type 2 diabetes mellitus. Curr Diab Rep. 2022;22:95–115.10.1007/s11892-022-01453-4Suche in Google Scholar PubMed PubMed Central

[7] Li Y, Teng D, Shi X, Qin G, Qin Y, Quan H, et al. Prevalence of diabetes recorded in mainland China using 2018 diagnostic criteria from the American Diabetes Association: national cross sectional study. bmj. 2020;369:m997.10.1136/bmj.m997Suche in Google Scholar PubMed PubMed Central

[8] Teodoro JS, Nunes S, Rolo AP, Reis F, Palmeira CM. Therapeutic options targeting oxidative stress, mitochondrial dysfunction and inflammation to hinder the progression of vascular complications of diabetes. Front Physiol. 2019;9:1857.10.3389/fphys.2018.01857Suche in Google Scholar PubMed PubMed Central

[9] Arunachalam K, Sreeja PS, Yang X. The antioxidant properties of mushroom polysaccharides can potentially mitigate oxidative stress, beta-cell dysfunction and insulin resistance. Front Pharm. 2022;13:874474.10.3389/fphar.2022.874474Suche in Google Scholar PubMed PubMed Central

[10] Lin W-R, Liu K-H, Ling T-C, Wang M-C, Lin W-H. Role of antidiabetic agents in type 2 diabetes patients with chronic kidney disease. World J Diabetes. 2023;14:352–63.10.4239/wjd.v14.i4.352Suche in Google Scholar PubMed PubMed Central

[11] Antar SA, Ashour NA, Sharaky M, Khattab M, Ashour NA, Zaid RT, et al. Diabetes mellitus: Classification, mediators, and complications; A gate to identify potential targets for the development of new effective treatments. Biomed Pharmacoth. 2023;168:115734.10.1016/j.biopha.2023.115734Suche in Google Scholar PubMed

[12] Ahmad E, Jahangeer M, Bukhari NI, Sarwar A, Aziz T, Alharbi M, et al. Isolation, structure elucidation & antidiabetic potential of Rosa brunonii L. fruit–fight diabetes with natural remedies. J Chil Chem Soc. 2023;68:5887–94.10.4067/s0717-97072023000205887Suche in Google Scholar

[13] Yuldasheva N, Acikyildiz N, Akyuz M, Yabo-Dambagi L, Aydin T, Cakir A, et al. The Synthesis of Schiff bases and new secondary amine derivatives of p-vanillin and evaluation of their neuroprotective, antidiabetic, antidepressant and antioxidant potentials. J Mol Struct. 2022;1270:133883.10.1016/j.molstruc.2022.133883Suche in Google Scholar

[14] Salihović M, Pazalja M, Špirtović Halilović S, Veljović E, Mahmutović-Dizdarević I, Roca S, et al. Synthesis, characterization, antimicrobial activity and DFT study of some novel Schiff bases. J Mol Struct. 2021;1241:130670.10.1016/j.molstruc.2021.130670Suche in Google Scholar

[15] Wei L, Zhang J, Tan W, Wang G, Li Q, Dong F, et al. Antifungal activity of double Schiff bases of chitosan derivatives bearing active halogeno-benzenes. Int J Bio Macromol. 2021;179:292–8.10.1016/j.ijbiomac.2021.02.184Suche in Google Scholar PubMed

[16] Wang Y-E, Yang D, Huo J, Chen L, Kang Z, Mao J, et al. Design, synthesis, and herbicidal activity of thioether containing 1, 2, 4-triazole schiff bases as transketolase inhibitors. J Agric Food Chem. 2021;69:11773–80.10.1021/acs.jafc.1c01804Suche in Google Scholar PubMed

[17] Alfonso-Herrera LA, Rosete-Luna S, Hernández-Romero D, Rivera-Villanueva JM, Olivares-Romero JL, Cruz-Navarro JA, et al. Transition metal complexes with tridentate schiff bases (ONO and ONN) derived from salicylaldehyde: an analysis of their potential anticancer activity. ChemMedChem. 2022;17:e202200367.10.1002/cmdc.202200367Suche in Google Scholar PubMed PubMed Central

[18] Pattanayak P, Kaliyaperumal S. Design, synthesis, characterization and in vitro antimicrobial and anthelmintic evaluation of metronidazole derivatives modified at position 1. Pharm Chem J. 2022;56:191–6.10.1007/s11094-022-02620-3Suche in Google Scholar

[19] Bhandarkar S, Pathare P, Khobragade B. New nickel (II), copper (II) and cobalt (II) complexes based salicyaldehyde schiff base: synthesis, characterisation, and antiviral activity. Mater Today: Proc. 2023;92:807–16.10.1016/j.matpr.2023.04.381Suche in Google Scholar

[20] Kaushik S, Paliwal SK, Iyer MR, Patil VM. Promising Schiff bases in antiviral drug design and discovery. Med Chem Res. 2023;32:1063–76.10.1007/s00044-023-03068-0Suche in Google Scholar PubMed PubMed Central

[21] Beteck RM, Isaacs M, Legoabe LJ, Hoppe HC, Tam CC, Kim JH, et al. Synthesis and in vitro antiprotozoal evaluation of novel metronidazole–Schiff base hybrids. Arch Pharm. 2023;356:2200409.10.1002/ardp.202200409Suche in Google Scholar PubMed

[22] Nilkanth PR, Ghorai SK, Sathiyanarayanan A, Dhawale K, Ahamad T, Gawande MB, et al. Synthesis and evaluation of anticonvulsant activity of some schiff bases of 7‐Amino‐1, 3‐dihydro‐2H‐1, 4‐benzodiazepin‐2‐one. Chem Biodiv. 2020;17:e2000342.10.1002/cbdv.202000342Suche in Google Scholar PubMed

[23] Hamid SJ, Salih T. Design, synthesis, and anti-inflammatory activity of some coumarin Schiff base derivatives: In silico and in vitro study. Drug Des Dev Ther. 2022;16:2275–88.10.2147/DDDT.S364746Suche in Google Scholar PubMed PubMed Central

[24] Deepika P, Vinusha HM, Begum M, Ramu R, Shirahatti PS, Nagendra Prasad MN. 2-methoxy-4-(((5-nitropyridin-2-yl) imino) methyl) phenol Schiff base ligand and its Cu (II) and Zn (II) complexes: synthesis, characterization and biological investigations. Heliyon. 2022;8(6):e09648.10.1016/j.heliyon.2022.e09648Suche in Google Scholar PubMed PubMed Central

[25] Afzal HR, Khan N, Sultana K, Mobashar A, Lareb A, Khan A, et al. Schiff bases of pioglitazone provide better antidiabetic and potent antioxidant effect in a streptozotocin–nicotinamide-induced diabetic rodent model. ACS Omega. 2021;6:4470–9.10.1021/acsomega.0c06064Suche in Google Scholar PubMed PubMed Central

[26] Abdel-Baky YM, Omer AM, El-Fakharany EM, Ammar YA, Abusaif MS, Ragab A. Developing a new multi-featured chitosan-quinoline Schiff base with potent antibacterial, antioxidant, and antidiabetic activities: Design and molecular modeling simulation. Sci Rep. 2023;13:22792.10.1038/s41598-023-50130-3Suche in Google Scholar PubMed PubMed Central

[27] Adeleke AA, Oladipo SD, Luckay RC, Akintemi EO, Olofinsan KA, Babatunde Onajobi I, et al. Synthesis and therapeutic potential of selected schiff bases: in vitro antibacterial, antioxidant, antidiabetic, and computational studies. Chem Select. 2024;9:e202304967.10.1002/slct.202304967Suche in Google Scholar

[28] Ceyhan SM, Zengin İN, Bingul M, Sahin H, Boga M, Saglam MF, et al. Indolyl imine compounds as multi-target agents; synthesis, antidiabetic, anticholinesterase, antioxidant activities and molecular modeling. J Mol Struct. 2024;1309:138159.10.1016/j.molstruc.2024.138159Suche in Google Scholar

[29] Cimerman Z, Miljanić S, Galić N. Schiff bases derived from aminopyridines as spectrofluorimetric analytical reagents. Croat Chem Acta. 2000;73:81–95.10.1002/chin.200019025Suche in Google Scholar

[30] Ermiş E, Aydın A, Ünver H, Sezen S, Mutlu MB. Microwave assisted synthesis, experimental and theoretical characterization and antibacterial activity screening of novel azomethine compounds containing thiophene and aminophenol functionality. Spectrochim Acta Part A: Mol Biomol Spectrosc. 2020;243:118761.10.1016/j.saa.2020.118761Suche in Google Scholar PubMed

[31] Raczuk E, Dmochowska B, Samaszko-Fiertek J, Madaj J. Different Schiff bases – structure, importance and classification. Molecules. 2022;27(3):787.10.3390/molecules27030787Suche in Google Scholar PubMed PubMed Central

[32] Pathan IR, Patel MK. A comprehensive review on the synthesis and applications of Schiff base ligand and metal complexes: A comparative study of conventional heating, microwave heating, and sonochemical methods. Inorg Chem Commun. 2023;158:111464.10.1016/j.inoche.2023.111464Suche in Google Scholar

[33] Bairwa SK, Sonera SA, Tandel R. Cholesterol based mesogenic Schiff’s base derivatives with carbonate linkage: Synthesis, characterisation and photoluminescence study. Liq Crystals. 2023;50:1–15.10.1080/02678292.2023.2260773Suche in Google Scholar

[34] Hussain H, Ahmad S, Shah SWA, Ullah A, Almehmadi M, Abdulaziz O, et al. Investigation of antistress and antidepressant activities of synthetic curcumin analogues: Behavioral and biomarker approach. Biomedicines. 2022;10:2385.10.3390/biomedicines10102385Suche in Google Scholar PubMed PubMed Central

[35] Uddin J, Shah SWA, Zahoor M, Ullah R, Alotaibi A. Chalcones: The flavonoid derivatives synthesis, characterization, their antioxidant and in vitro/in vivo antidiabetic potentials. Heliyon. 2023;9(11):e22546.10.1016/j.heliyon.2023.e22546Suche in Google Scholar PubMed PubMed Central

[36] Davies GF. Harm-benefit analysis: opportunities for enhancing ethical review in animal research. Lab Anim. 2018;47(3):57–8.10.1038/s41684-018-0002-2Suche in Google Scholar PubMed

[37] Anwar T, Kumar P, Khan AU. Modern tools and techniques in computer-aided drug design. In Molecular docking for computer-aided drug design. Oxford, UK: Academic Press; 2021. p. 1–30.10.1016/B978-0-12-822312-3.00011-4Suche in Google Scholar

[38] Inc CCG. Molecular operating environment (MOE). Cambridge, UK: Chemical Computing Group Inc. 2016. p. 1010.Suche in Google Scholar

[39] Šali A, Blundell TL. Comparative protein modelling by satisfaction of spatial restraints. J Mol Bio. 1993;234:779–815.10.1006/jmbi.1993.1626Suche in Google Scholar PubMed

[40] Evans DA. History of the Harvard ChemDraw project. Angew Chem, Int Ed. 2014;42:11140–5.10.1002/anie.201405820Suche in Google Scholar PubMed

[41] Guan L, Yang H, Cai Y, Sun L, Di P, Li W, et al. ADMET-score–a comprehensive scoring function for evaluation of chemical drug-likeness. Medchemcomm. 2019;10:148–57.10.1039/C8MD00472BSuche in Google Scholar PubMed PubMed Central

[42] Daina A, Michielin O, Zoete V. SwissADME: a free web tool to evaluate pharmacokinetics, drug-likeness and medicinal chemistry friendliness of small molecules. Sci Rep. 2017;7:42717.10.1038/srep42717Suche in Google Scholar PubMed PubMed Central

[43] Pires DE, Blundell TL, Ascher DB. pkCSM: predicting small-molecule pharmacokinetic and toxicity properties using graph-based signatures. J Med Chem. 2015;58:4066–72.10.1021/acs.jmedchem.5b00104Suche in Google Scholar PubMed PubMed Central

[44] Banerjee P, Eckert AO, Schrey AK, Preissner R. ProTox-II: a webserver for the prediction of toxicity of chemicals. Nucleic Acids Res. 2018;46:W257–63.10.1093/nar/gky318Suche in Google Scholar PubMed PubMed Central

[45] Yan D, Wu X, Xiao J, Zhu Z, Xu X, Bao X, et al. n-Butyllithium catalyzed hydroboration of imines and alkynes. Org Chem Front. 2019;6:648–53.10.1039/C8QO01289JSuche in Google Scholar

[46] Das K, Mondal A, Pal D, Srivastava HK, Srimani D. Phosphine-free well-defined Mn (I) complex-catalyzed synthesis of amine, imine, and 2, 3-dihydro-1 H-perimidine via hydrogen autotransfer or acceptorless dehydrogenative coupling of amine and alcohol. Organometallics. 2019;38:1815–25.10.1021/acs.organomet.9b00131Suche in Google Scholar

[47] Neelofar N, Ali N, Khan A, Amir S, A. Khan N, Bilal M. Synthesis of Schiff bases derived from 2-hydroxy-1-naphth-aldehyde and their tin (II) complexes for antimicribial and antioxidant activities. Bull Chem Soc Ethiopia. 2017;31:445–56.10.4314/bcse.v31i3.8Suche in Google Scholar

[48] Wahab A, Haider SS, Mahmood I. Synthesis of Schiff bases from natural products and their remarkable antimicrobial and antioxidant activity. FUUAST J Bio. 2014;4:27–32.Suche in Google Scholar

[49] Guo Z, Xing R, Liu S, Yu H, Wang P, Li C, et al. The synthesis and antioxidant activity of the Schiff bases of chitosan and carboxymethyl chitosan. Bioorg Med Chem Lett. 2005;15:4600–3.10.1016/j.bmcl.2005.06.095Suche in Google Scholar PubMed

[50] Popov LD, Borodkin SA, Kiskin MA, Pavlov AA, Knyazev PA, Chernyavina VV, et al. Synthesis and crystal structure of cobalt (III) chelate with tridentate azomethine ligand containing a benzimidazole moiety. Russ J Coord. 2022;48(1):9–15.10.1134/S1070328421110038Suche in Google Scholar

[51] Mazhar N, Aftab M, Mahmud T, Basra MR, Akhtar M, Mitu L. Synthesis, characterization and biological evaluation of new schiff base ligand derived from 3-hydroxy-benzaldehyde and p-toluidine and its divalent metal ions. Rev Chim. 2020;71:47–58.10.37358/RC.20.4.8042Suche in Google Scholar

[52] Cseh L, Csunderlik C, Pantenburg I, Meyer G, Costisor O. Synthesis, crystal structure, and spectral properties of a cobalt (II) complex with N‐salicylidene‐p‐toluidine. Zeitsch Anorg Allg. 2003;629:985–8.10.1002/zaac.200200438Suche in Google Scholar

[53] El‐Sonbati AZ, Mahmoud WH, Mohamed GG, Diab MA, Morgan SM, Abbas SY. Synthesis, characterization of Schiff base metal complexes and their biological investigation. App Organomet Chem. 2019;33:e5048.10.1002/aoc.5048Suche in Google Scholar

[54] Santos JA, Lima RM, Pereira TV, Carmo AMR, Raposo NRB, Barbosa NR, et al. Antioxidant activity of thio-Schiff bases. Lett Drug Des Disc. 2013;10:557–60.10.2174/1570180811310070002Suche in Google Scholar

[55] Aytac S, Gundogdu O, Bingol Z, Gulcin I. Synthesis of Schiff bases containing phenol rings and investigation of their antioxidant capacity, anticholinesterase, butyrylcholinesterase, and carbonic anhydrase inhibition properties. Pharmaceutics. 2023;15:779.10.3390/pharmaceutics15030779Suche in Google Scholar PubMed PubMed Central

[56] Buldurun K, Turan N, Bursal E, Mantarcı A, Turkan F, Taslimi P, et al. Synthesis, spectroscopic properties, crystal structures, antioxidant activities and enzyme inhibition determination of Co (II) and Fe (II) complexes of Schiff base. Res Chem Intermed. 2020;46:283–97.10.1007/s11164-019-03949-3Suche in Google Scholar

[57] Zhang Y, Zou B, Chen Z, Pan Y, Wang H, Liang H, et al. Synthesis and antioxidant activities of novel 4-Schiff base-7-benzyloxy-coumarin derivatives. Bioorg Med Chem Let. 2011;21:6811–5.10.1016/j.bmcl.2011.09.029Suche in Google Scholar PubMed

[58] Okoli BJ, Modise JS. Investigation into the thermal response and pharmacological activity of substituted Schiff Bases on α-Amylase and α-Glucosidase. Antioxidants. 2018;7:113.10.3390/antiox7090113Suche in Google Scholar PubMed PubMed Central

[59] Xiao J, Ni X, Kai G, Chen X. A review on structure–activity relationship of dietary polyphenols inhibiting α-amylase. Crit Rev Food Sci Nutr. 2013;53:497–506.10.1080/10408398.2010.548108Suche in Google Scholar PubMed

[60] Ahmed KS, Milosavić N, Popović MM, Prodanović R, Knežević Z, Jankov R. Preparation and studies on immobilized α-glucosidase from baker’s yeast Saccharomyces cerevisiae. J Serb Chem Soc. 2007;72:1255–63.10.2298/JSC0712255ASuche in Google Scholar

[61] Imtiaz F, Islam M, Saeed H, Ahmed A, Asghar M, Saleem B, et al. Novel phytoniosomes formulation of Tradescantia pallida leaves attenuates diabetes more effectively than pure extract. J Drug Deliv Sci Technol. 2023;83:104399.10.1016/j.jddst.2023.104399Suche in Google Scholar

[62] Tariq S, Mirza MR, Choudhary MI, Sultan R, Zafar M. Prediction of type 2 diabetes at pre-diabetes stage by mass spectrometry: a preliminary study. Int J Pept Res Ther. 2022;28:111.10.1007/s10989-022-10419-9Suche in Google Scholar

[63] Al-Qadsy I, Saeed WS, Al-Odayni AB, Alrabie A, Al-Faqeeh LAS, Al-Adhreai A, et al. Antidiabetic, antioxidant and cytotoxicity activities of ortho-and para-substituted Schiff bases derived from metformin hydrochloride: Validation by molecular docking and in silico ADME studies. Open Chem. 2023;21:20230125.10.1515/chem-2023-0125Suche in Google Scholar

[64] Gebremeskel L, Beshir Tuem K, Teklu T. Evaluation of antidiabetic effect of ethanolic leaves extract of Becium grandiflorum Lam.(Lamiaceae) in streptozotocin-induced diabetic mice. Diabetes Metab Syndr Obes. 2020;13:1481–9.10.2147/DMSO.S246996Suche in Google Scholar PubMed PubMed Central

[65] Mabuza LP, Gamede MW, Maikoo S, Booysen IN, Ngubane PS, Khathi A. Effects of a ruthenium schiff base complex on glucose homeostasis in diet-induced pre-diabetic rats. Molecules. 2018;23:1721.10.3390/molecules23071721Suche in Google Scholar PubMed PubMed Central

[66] Hostalek U, Gwilt M, Hildemann S. Therapeutic use of metformin in prediabetes and diabetes prevention. Drugs. 2015;75:1071–94.10.1007/s40265-015-0416-8Suche in Google Scholar PubMed PubMed Central

[67] Imtiaz F, Islam M, Saeed H, Ahmed A, Rathore HA. Assessment of the antidiabetic potential of extract and novel phytoniosomes formulation of Tradescantia pallida leaves in the alloxan‐induced diabetic mouse model. FASEB J. 2023;37:e22818.10.1096/fj.202201395RRSuche in Google Scholar PubMed

[68] Adalat B, Rahim F, Taha M, Hayat S, Iqbal N, Ali Z, et al. Synthesis of Benzofuran–based Schiff bases as anti-diabetic compounds and their molecular docking studies. J Mol Struct. 2022;1265:133287.10.1016/j.molstruc.2022.133287Suche in Google Scholar

[69] Smith DL, Orlandella RM, Allison DB, Norian LA. Diabetes medications as potential calorie restriction mimetics—a focus on the alpha-glucosidase inhibitor acarbose. GeroSci. 2021;43:1123–33.10.1007/s11357-020-00278-xSuche in Google Scholar PubMed PubMed Central

[70] Imtiaz F, Islam M, Saeed H, Ishaq M, Shareef U, Qaisar MN, et al. HPLC profiling for the simultaneous estimation of antidiabetic compounds from Tradescantia pallida. Arab J Chem. 2024;17:105703.10.1016/j.arabjc.2024.105703Suche in Google Scholar

[71] Imtiaz F, Islam M, Saeed H, Ahmed A, Hashmi FK, Khan KM, et al. Prediction of α-glucosidase inhibitory activity of LC-ESI-TQ-MS/MS-identified compounds from Tradescantia pallida leaves. Pharmaceutics. 2022;14:2578.10.3390/pharmaceutics14122578Suche in Google Scholar PubMed PubMed Central

[72] Imtiaz F, Islam M, Saeed H, Ahmed A. Phenolic compounds from Tradescantia pallida ameliorate diabetes by inhibiting enzymatic and non-enzymatic pathways. J Biomol Struct Dyn. 2023;41:11872–88.10.1080/07391102.2022.2164059Suche in Google Scholar PubMed

[73] Akmal M, Patel P, Wadhwa R. Alpha glucosidase inhibitors. In StatPearls [internet]. Florida, USA: StatPearls Publishing; 2024.Suche in Google Scholar

[74] Lipinski CA, Lombardo F, Dominy BW, Feeney PJ. Experimental and computational approaches to estimate solubility and permeability in drug discovery and development settings. Adv Drug Deliv Rev. 2012;64:4–17.10.1016/j.addr.2012.09.019Suche in Google Scholar

[75] Vlad IM, Nuta DC, Chirita C, Caproiu MT, Draghici C, Dumitrascu F, et al. In silico and in vitro experimental studies of new dibenz [b, e] oxepin-11 (6 H) one O-(arylcarbamoyl)-oximes designed as potential antimicrobial agents. Molecules. 2020;25:321.10.3390/molecules25020321Suche in Google Scholar PubMed PubMed Central

[76] Garrido A, Lepailleur A, Mignani SM, Dallemagne P, Rochais C. hERG toxicity assessment: Useful guidelines for drug design. Eur J Med Chem. 2020;195:112290.10.1016/j.ejmech.2020.112290Suche in Google Scholar PubMed

Received: 2024-06-01
Revised: 2024-08-03
Accepted: 2024-08-27
Published Online: 2024-09-23

© 2024 the author(s), published by De Gruyter

This work is licensed under the Creative Commons Attribution 4.0 International License.

Artikel in diesem Heft

  1. Regular Articles
  2. Porous silicon nanostructures: Synthesis, characterization, and their antifungal activity
  3. Biochar from de-oiled Chlorella vulgaris and its adsorption on antibiotics
  4. Phytochemicals profiling, in vitro and in vivo antidiabetic activity, and in silico studies on Ajuga iva (L.) Schreb.: A comprehensive approach
  5. Synthesis, characterization, in silico and in vitro studies of novel glycoconjugates as potential antibacterial, antifungal, and antileishmanial agents
  6. Sonochemical synthesis of gold nanoparticles mediated by potato starch: Its performance in the treatment of esophageal cancer
  7. Computational study of ADME-Tox prediction of selected phytochemicals from Punica granatum peels
  8. Phytochemical analysis, in vitro antioxidant and antifungal activities of extracts and essential oil derived from Artemisia herba-alba Asso
  9. Two triazole-based coordination polymers: Synthesis and crystal structure characterization
  10. Phytochemical and physicochemical studies of different apple varieties grown in Morocco
  11. Synthesis of multi-template molecularly imprinted polymers (MT-MIPs) for isolating ethyl para-methoxycinnamate and ethyl cinnamate from Kaempferia galanga L., extract with methacrylic acid as functional monomer
  12. Nutraceutical potential of Mesembryanthemum forsskaolii Hochst. ex Bioss.: Insights into its nutritional composition, phytochemical contents, and antioxidant activity
  13. Evaluation of influence of Butea monosperma floral extract on inflammatory biomarkers
  14. Cannabis sativa L. essential oil: Chemical composition, anti-oxidant, anti-microbial properties, and acute toxicity: In vitro, in vivo, and in silico study
  15. The effect of gamma radiation on 5-hydroxymethylfurfural conversion in water and dimethyl sulfoxide
  16. Hollow mushroom nanomaterials for potentiometric sensing of Pb2+ ions in water via the intercalation of iodide ions into the polypyrrole matrix
  17. Determination of essential oil and chemical composition of St. John’s Wort
  18. Computational design and in vitro assay of lantadene-based novel inhibitors of NS3 protease of dengue virus
  19. Anti-parasitic activity and computational studies on a novel labdane diterpene from the roots of Vachellia nilotica
  20. Microbial dynamics and dehydrogenase activity in tomato (Lycopersicon esculentum Mill.) rhizospheres: Impacts on growth and soil health across different soil types
  21. Correlation between in vitro anti-urease activity and in silico molecular modeling approach of novel imidazopyridine–oxadiazole hybrids derivatives
  22. Spatial mapping of indoor air quality in a light metro system using the geographic information system method
  23. Iron indices and hemogram in renal anemia and the improvement with Tribulus terrestris green-formulated silver nanoparticles applied on rat model
  24. Integrated track of nano-informatics coupling with the enrichment concept in developing a novel nanoparticle targeting ERK protein in Naegleria fowleri
  25. Cytotoxic and phytochemical screening of Solanum lycopersicum–Daucus carota hydro-ethanolic extract and in silico evaluation of its lycopene content as anticancer agent
  26. Protective activities of silver nanoparticles containing Panax japonicus on apoptotic, inflammatory, and oxidative alterations in isoproterenol-induced cardiotoxicity
  27. pH-based colorimetric detection of monofunctional aldehydes in liquid and gas phases
  28. Investigating the effect of resveratrol on apoptosis and regulation of gene expression of Caco-2 cells: Unravelling potential implications for colorectal cancer treatment
  29. Metformin inhibits knee osteoarthritis induced by type 2 diabetes mellitus in rats: S100A8/9 and S100A12 as players and therapeutic targets
  30. Effect of silver nanoparticles formulated by Silybum marianum on menopausal urinary incontinence in ovariectomized rats
  31. Synthesis of new analogs of N-substituted(benzoylamino)-1,2,3,6-tetrahydropyridines
  32. Response of yield and quality of Japonica rice to different gradients of moisture deficit at grain-filling stage in cold regions
  33. Preparation of an inclusion complex of nickel-based β-cyclodextrin: Characterization and accelerating the osteoarthritis articular cartilage repair
  34. Empagliflozin-loaded nanomicelles responsive to reactive oxygen species for renal ischemia/reperfusion injury protection
  35. Preparation and pharmacodynamic evaluation of sodium aescinate solid lipid nanoparticles
  36. Assessment of potentially toxic elements and health risks of agricultural soil in Southwest Riyadh, Saudi Arabia
  37. Theoretical investigation of hydrogen-rich fuel production through ammonia decomposition
  38. Biosynthesis and screening of cobalt nanoparticles using citrus species for antimicrobial activity
  39. Investigating the interplay of genetic variations, MCP-1 polymorphism, and docking with phytochemical inhibitors for combatting dengue virus pathogenicity through in silico analysis
  40. Ultrasound induced biosynthesis of silver nanoparticles embedded into chitosan polymers: Investigation of its anti-cutaneous squamous cell carcinoma effects
  41. Copper oxide nanoparticles-mediated Heliotropium bacciferum leaf extract: Antifungal activity and molecular docking assays against strawberry pathogens
  42. Sprouted wheat flour for improving physical, chemical, rheological, microbial load, and quality properties of fino bread
  43. Comparative toxicity assessment of fisetin-aided artificial intelligence-assisted drug design targeting epibulbar dermoid through phytochemicals
  44. Acute toxicity and anti-inflammatory activity of bis-thiourea derivatives
  45. Anti-diabetic activity-guided isolation of α-amylase and α-glucosidase inhibitory terpenes from Capsella bursa-pastoris Linn.
  46. GC–MS analysis of Lactobacillus plantarum YW11 metabolites and its computational analysis on familial pulmonary fibrosis hub genes
  47. Green formulation of copper nanoparticles by Pistacia khinjuk leaf aqueous extract: Introducing a novel chemotherapeutic drug for the treatment of prostate cancer
  48. Improved photocatalytic properties of WO3 nanoparticles for Malachite green dye degradation under visible light irradiation: An effect of La doping
  49. One-pot synthesis of a network of Mn2O3–MnO2–poly(m-methylaniline) composite nanorods on a polypyrrole film presents a promising and efficient optoelectronic and solar cell device
  50. Groundwater quality and health risk assessment of nitrate and fluoride in Al Qaseem area, Saudi Arabia
  51. A comparative study of the antifungal efficacy and phytochemical composition of date palm leaflet extracts
  52. Processing of alcohol pomelo beverage (Citrus grandis (L.) Osbeck) using saccharomyces yeast: Optimization, physicochemical quality, and sensory characteristics
  53. Specialized compounds of four Cameroonian spices: Isolation, characterization, and in silico evaluation as prospective SARS-CoV-2 inhibitors
  54. Identification of a novel drug target in Porphyromonas gingivalis by a computational genome analysis approach
  55. Physico-chemical properties and durability of a fly-ash-based geopolymer
  56. FMS-like tyrosine kinase 3 inhibitory potentials of some phytochemicals from anti-leukemic plants using computational chemical methodologies
  57. Wild Thymus zygis L. ssp. gracilis and Eucalyptus camaldulensis Dehnh.: Chemical composition, antioxidant and antibacterial activities of essential oils
  58. 3D-QSAR, molecular docking, ADMET, simulation dynamic, and retrosynthesis studies on new styrylquinolines derivatives against breast cancer
  59. Deciphering the influenza neuraminidase inhibitory potential of naturally occurring biflavonoids: An in silico approach
  60. Determination of heavy elements in agricultural regions, Saudi Arabia
  61. Synthesis and characterization of antioxidant-enriched Moringa oil-based edible oleogel
  62. Ameliorative effects of thistle and thyme honeys on cyclophosphamide-induced toxicity in mice
  63. Study of phytochemical compound and antipyretic activity of Chenopodium ambrosioides L. fractions
  64. Investigating the adsorption mechanism of zinc chloride-modified porous carbon for sulfadiazine removal from water
  65. Performance repair of building materials using alumina and silica composite nanomaterials with electrodynamic properties
  66. Effects of nanoparticles on the activity and resistance genes of anaerobic digestion enzymes in livestock and poultry manure containing the antibiotic tetracycline
  67. Effect of copper nanoparticles green-synthesized using Ocimum basilicum against Pseudomonas aeruginosa in mice lung infection model
  68. Cardioprotective effects of nanoparticles green formulated by Spinacia oleracea extract on isoproterenol-induced myocardial infarction in mice by the determination of PPAR-γ/NF-κB pathway
  69. Anti-OTC antibody-conjugated fluorescent magnetic/silica and fluorescent hybrid silica nanoparticles for oxytetracycline detection
  70. Curcumin conjugated zinc nanoparticles for the treatment of myocardial infarction
  71. Identification and in silico screening of natural phloroglucinols as potential PI3Kα inhibitors: A computational approach for drug discovery
  72. Exploring the phytochemical profile and antioxidant evaluation: Molecular docking and ADMET analysis of main compounds from three Solanum species in Saudi Arabia
  73. Unveiling the molecular composition and biological properties of essential oil derived from the leaves of wild Mentha aquatica L.: A comprehensive in vitro and in silico exploration
  74. Analysis of bioactive compounds present in Boerhavia elegans seeds by GC-MS
  75. Homology modeling and molecular docking study of corticotrophin-releasing hormone: An approach to treat stress-related diseases
  76. LncRNA MIR17HG alleviates heart failure via targeting MIR17HG/miR-153-3p/SIRT1 axis in in vitro model
  77. Development and validation of a stability indicating UPLC-DAD method coupled with MS-TQD for ramipril and thymoquinone in bioactive SNEDDS with in silico toxicity analysis of ramipril degradation products
  78. Biosynthesis of Ag/Cu nanocomposite mediated by Curcuma longa: Evaluation of its antibacterial properties against oral pathogens
  79. Development of AMBER-compliant transferable force field parameters for polytetrafluoroethylene
  80. Treatment of gestational diabetes by Acroptilon repens leaf aqueous extract green-formulated iron nanoparticles in rats
  81. Development and characterization of new ecological adsorbents based on cardoon wastes: Application to brilliant green adsorption
  82. A fast, sensitive, greener, and stability-indicating HPLC method for the standardization and quantitative determination of chlorhexidine acetate in commercial products
  83. Assessment of Se, As, Cd, Cr, Hg, and Pb content status in Ankang tea plantations of China
  84. Effect of transition metal chloride (ZnCl2) on low-temperature pyrolysis of high ash bituminous coal
  85. Evaluating polyphenol and ascorbic acid contents, tannin removal ability, and physical properties during hydrolysis and convective hot-air drying of cashew apple powder
  86. Development and characterization of functional low-fat frozen dairy dessert enhanced with dried lemongrass powder
  87. Scrutinizing the effect of additive and synergistic antibiotics against carbapenem-resistant Pseudomonas aeruginosa
  88. Preparation, characterization, and determination of the therapeutic effects of copper nanoparticles green-formulated by Pistacia atlantica in diabetes-induced cardiac dysfunction in rat
  89. Antioxidant and antidiabetic potentials of methoxy-substituted Schiff bases using in vitro, in vivo, and molecular simulation approaches
  90. Anti-melanoma cancer activity and chemical profile of the essential oil of Seseli yunnanense Franch
  91. Molecular docking analysis of subtilisin-like alkaline serine protease (SLASP) and laccase with natural biopolymers
  92. Overcoming methicillin resistance by methicillin-resistant Staphylococcus aureus: Computational evaluation of napthyridine and oxadiazoles compounds for potential dual inhibition of PBP-2a and FemA proteins
  93. Exploring novel antitubercular agents: Innovative design of 2,3-diaryl-quinoxalines targeting DprE1 for effective tuberculosis treatment
  94. Drimia maritima flowers as a source of biologically potent components: Optimization of bioactive compound extractions, isolation, UPLC–ESI–MS/MS, and pharmacological properties
  95. Estimating molecular properties, drug-likeness, cardiotoxic risk, liability profile, and molecular docking study to characterize binding process of key phyto-compounds against serotonin 5-HT2A receptor
  96. Fabrication of β-cyclodextrin-based microgels for enhancing solubility of Terbinafine: An in-vitro and in-vivo toxicological evaluation
  97. Phyto-mediated synthesis of ZnO nanoparticles and their sunlight-driven photocatalytic degradation of cationic and anionic dyes
  98. Monosodium glutamate induces hypothalamic–pituitary–adrenal axis hyperactivation, glucocorticoid receptors down-regulation, and systemic inflammatory response in young male rats: Impact on miR-155 and miR-218
  99. Quality control analyses of selected honey samples from Serbia based on their mineral and flavonoid profiles, and the invertase activity
  100. Eco-friendly synthesis of silver nanoparticles using Phyllanthus niruri leaf extract: Assessment of antimicrobial activity, effectiveness on tropical neglected mosquito vector control, and biocompatibility using a fibroblast cell line model
  101. Green synthesis of silver nanoparticles containing Cichorium intybus to treat the sepsis-induced DNA damage in the liver of Wistar albino rats
  102. Quality changes of durian pulp (Durio ziberhinus Murr.) in cold storage
  103. Study on recrystallization process of nitroguanidine by directly adding cold water to control temperature
  104. Determination of heavy metals and health risk assessment in drinking water in Bukayriyah City, Saudi Arabia
  105. Larvicidal properties of essential oils of three Artemisia species against the chemically insecticide-resistant Nile fever vector Culex pipiens (L.) (Diptera: Culicidae): In vitro and in silico studies
  106. Design, synthesis, characterization, and theoretical calculations, along with in silico and in vitro antimicrobial proprieties of new isoxazole-amide conjugates
  107. The impact of drying and extraction methods on total lipid, fatty acid profile, and cytotoxicity of Tenebrio molitor larvae
  108. A zinc oxide–tin oxide–nerolidol hybrid nanomaterial: Efficacy against esophageal squamous cell carcinoma
  109. Research on technological process for production of muskmelon juice (Cucumis melo L.)
  110. Physicochemical components, antioxidant activity, and predictive models for quality of soursop tea (Annona muricata L.) during heat pump drying
  111. Characterization and application of Fe1−xCoxFe2O4 nanoparticles in Direct Red 79 adsorption
  112. Torilis arvensis ethanolic extract: Phytochemical analysis, antifungal efficacy, and cytotoxicity properties
  113. Magnetite–poly-1H pyrrole dendritic nanocomposite seeded on poly-1H pyrrole: A promising photocathode for green hydrogen generation from sanitation water without using external sacrificing agent
  114. HPLC and GC–MS analyses of phytochemical compounds in Haloxylon salicornicum extract: Antibacterial and antifungal activity assessment of phytopathogens
  115. Efficient and stable to coking catalysts of ethanol steam reforming comprised of Ni + Ru loaded on MgAl2O4 + LnFe0.7Ni0.3O3 (Ln = La, Pr) nanocomposites prepared via cost-effective procedure with Pluronic P123 copolymer
  116. Nitrogen and boron co-doped carbon dots probe for selectively detecting Hg2+ in water samples and the detection mechanism
  117. Heavy metals in road dust from typical old industrial areas of Wuhan: Seasonal distribution and bioaccessibility-based health risk assessment
  118. Phytochemical profiling and bioactivity evaluation of CBD- and THC-enriched Cannabis sativa extracts: In vitro and in silico investigation of antioxidant and anti-inflammatory effects
  119. Investigating dye adsorption: The role of surface-modified montmorillonite nanoclay in kinetics, isotherms, and thermodynamics
  120. Antimicrobial activity, induction of ROS generation in HepG2 liver cancer cells, and chemical composition of Pterospermum heterophyllum
  121. Study on the performance of nanoparticle-modified PVDF membrane in delaying membrane aging
  122. Impact of cholesterol in encapsulated vitamin E acetate within cocoliposomes
  123. Review Articles
  124. Structural aspects of Pt(η3-X1N1X2)(PL) (X1,2 = O, C, or Se) and Pt(η3-N1N2X1)(PL) (X1 = C, S, or Se) derivatives
  125. Biosurfactants in biocorrosion and corrosion mitigation of metals: An overview
  126. Stimulus-responsive MOF–hydrogel composites: Classification, preparation, characterization, and their advancement in medical treatments
  127. Electrochemical dissolution of titanium under alternating current polarization to obtain its dioxide
  128. Special Issue on Recent Trends in Green Chemistry
  129. Phytochemical screening and antioxidant activity of Vitex agnus-castus L.
  130. Phytochemical study, antioxidant activity, and dermoprotective activity of Chenopodium ambrosioides (L.)
  131. Exploitation of mangliculous marine fungi, Amarenographium solium, for the green synthesis of silver nanoparticles and their activity against multiple drug-resistant bacteria
  132. Study of the phytotoxicity of margines on Pistia stratiotes L.
  133. Special Issue on Advanced Nanomaterials for Energy, Environmental and Biological Applications - Part III
  134. Impact of biogenic zinc oxide nanoparticles on growth, development, and antioxidant system of high protein content crop (Lablab purpureus L.) sweet
  135. Green synthesis, characterization, and application of iron and molybdenum nanoparticles and their composites for enhancing the growth of Solanum lycopersicum
  136. Green synthesis of silver nanoparticles from Olea europaea L. extracted polysaccharides, characterization, and its assessment as an antimicrobial agent against multiple pathogenic microbes
  137. Photocatalytic treatment of organic dyes using metal oxides and nanocomposites: A quantitative study
  138. Antifungal, antioxidant, and photocatalytic activities of greenly synthesized iron oxide nanoparticles
  139. Special Issue on Phytochemical and Pharmacological Scrutinization of Medicinal Plants
  140. Hepatoprotective effects of safranal on acetaminophen-induced hepatotoxicity in rats
  141. Chemical composition and biological properties of Thymus capitatus plants from Algerian high plains: A comparative and analytical study
  142. Chemical composition and bioactivities of the methanol root extracts of Saussurea costus
  143. In vivo protective effects of vitamin C against cyto-genotoxicity induced by Dysphania ambrosioides aqueous extract
  144. Insights about the deleterious impact of a carbamate pesticide on some metabolic immune and antioxidant functions and a focus on the protective ability of a Saharan shrub and its anti-edematous property
  145. A comprehensive review uncovering the anticancerous potential of genkwanin (plant-derived compound) in several human carcinomas
  146. A study to investigate the anticancer potential of carvacrol via targeting Notch signaling in breast cancer
  147. Assessment of anti-diabetic properties of Ziziphus oenopolia (L.) wild edible fruit extract: In vitro and in silico investigations through molecular docking analysis
  148. Optimization of polyphenol extraction, phenolic profile by LC-ESI-MS/MS, antioxidant, anti-enzymatic, and cytotoxic activities of Physalis acutifolia
  149. Phytochemical screening, antioxidant properties, and photo-protective activities of Salvia balansae de Noé ex Coss
  150. Antihyperglycemic, antiglycation, anti-hypercholesteremic, and toxicity evaluation with gas chromatography mass spectrometry profiling for Aloe armatissima leaves
  151. Phyto-fabrication and characterization of gold nanoparticles by using Timur (Zanthoxylum armatum DC) and their effect on wound healing
  152. Does Erodium trifolium (Cav.) Guitt exhibit medicinal properties? Response elements from phytochemical profiling, enzyme-inhibiting, and antioxidant and antimicrobial activities
  153. Integrative in silico evaluation of the antiviral potential of terpenoids and its metal complexes derived from Homalomena aromatica based on main protease of SARS-CoV-2
  154. 6-Methoxyflavone improves anxiety, depression, and memory by increasing monoamines in mice brain: HPLC analysis and in silico studies
  155. Simultaneous extraction and quantification of hydrophilic and lipophilic antioxidants in Solanum lycopersicum L. varieties marketed in Saudi Arabia
  156. Biological evaluation of CH3OH and C2H5OH of Berberis vulgaris for in vivo antileishmanial potential against Leishmania tropica in murine models
https://doi.org/10.1515/chem-2024-0083
Schlagwörter für diesen Artikel
Schiff’s bases; antidiabetic potential; diabetes; glibenclamide
Creative Commons
BY 4.0

Artikel in diesem Heft

  1. Regular Articles
  2. Porous silicon nanostructures: Synthesis, characterization, and their antifungal activity
  3. Biochar from de-oiled Chlorella vulgaris and its adsorption on antibiotics
  4. Phytochemicals profiling, in vitro and in vivo antidiabetic activity, and in silico studies on Ajuga iva (L.) Schreb.: A comprehensive approach
  5. Synthesis, characterization, in silico and in vitro studies of novel glycoconjugates as potential antibacterial, antifungal, and antileishmanial agents
  6. Sonochemical synthesis of gold nanoparticles mediated by potato starch: Its performance in the treatment of esophageal cancer
  7. Computational study of ADME-Tox prediction of selected phytochemicals from Punica granatum peels
  8. Phytochemical analysis, in vitro antioxidant and antifungal activities of extracts and essential oil derived from Artemisia herba-alba Asso
  9. Two triazole-based coordination polymers: Synthesis and crystal structure characterization
  10. Phytochemical and physicochemical studies of different apple varieties grown in Morocco
  11. Synthesis of multi-template molecularly imprinted polymers (MT-MIPs) for isolating ethyl para-methoxycinnamate and ethyl cinnamate from Kaempferia galanga L., extract with methacrylic acid as functional monomer
  12. Nutraceutical potential of Mesembryanthemum forsskaolii Hochst. ex Bioss.: Insights into its nutritional composition, phytochemical contents, and antioxidant activity
  13. Evaluation of influence of Butea monosperma floral extract on inflammatory biomarkers
  14. Cannabis sativa L. essential oil: Chemical composition, anti-oxidant, anti-microbial properties, and acute toxicity: In vitro, in vivo, and in silico study
  15. The effect of gamma radiation on 5-hydroxymethylfurfural conversion in water and dimethyl sulfoxide
  16. Hollow mushroom nanomaterials for potentiometric sensing of Pb2+ ions in water via the intercalation of iodide ions into the polypyrrole matrix
  17. Determination of essential oil and chemical composition of St. John’s Wort
  18. Computational design and in vitro assay of lantadene-based novel inhibitors of NS3 protease of dengue virus
  19. Anti-parasitic activity and computational studies on a novel labdane diterpene from the roots of Vachellia nilotica
  20. Microbial dynamics and dehydrogenase activity in tomato (Lycopersicon esculentum Mill.) rhizospheres: Impacts on growth and soil health across different soil types
  21. Correlation between in vitro anti-urease activity and in silico molecular modeling approach of novel imidazopyridine–oxadiazole hybrids derivatives
  22. Spatial mapping of indoor air quality in a light metro system using the geographic information system method
  23. Iron indices and hemogram in renal anemia and the improvement with Tribulus terrestris green-formulated silver nanoparticles applied on rat model
  24. Integrated track of nano-informatics coupling with the enrichment concept in developing a novel nanoparticle targeting ERK protein in Naegleria fowleri
  25. Cytotoxic and phytochemical screening of Solanum lycopersicum–Daucus carota hydro-ethanolic extract and in silico evaluation of its lycopene content as anticancer agent
  26. Protective activities of silver nanoparticles containing Panax japonicus on apoptotic, inflammatory, and oxidative alterations in isoproterenol-induced cardiotoxicity
  27. pH-based colorimetric detection of monofunctional aldehydes in liquid and gas phases
  28. Investigating the effect of resveratrol on apoptosis and regulation of gene expression of Caco-2 cells: Unravelling potential implications for colorectal cancer treatment
  29. Metformin inhibits knee osteoarthritis induced by type 2 diabetes mellitus in rats: S100A8/9 and S100A12 as players and therapeutic targets
  30. Effect of silver nanoparticles formulated by Silybum marianum on menopausal urinary incontinence in ovariectomized rats
  31. Synthesis of new analogs of N-substituted(benzoylamino)-1,2,3,6-tetrahydropyridines
  32. Response of yield and quality of Japonica rice to different gradients of moisture deficit at grain-filling stage in cold regions
  33. Preparation of an inclusion complex of nickel-based β-cyclodextrin: Characterization and accelerating the osteoarthritis articular cartilage repair
  34. Empagliflozin-loaded nanomicelles responsive to reactive oxygen species for renal ischemia/reperfusion injury protection
  35. Preparation and pharmacodynamic evaluation of sodium aescinate solid lipid nanoparticles
  36. Assessment of potentially toxic elements and health risks of agricultural soil in Southwest Riyadh, Saudi Arabia
  37. Theoretical investigation of hydrogen-rich fuel production through ammonia decomposition
  38. Biosynthesis and screening of cobalt nanoparticles using citrus species for antimicrobial activity
  39. Investigating the interplay of genetic variations, MCP-1 polymorphism, and docking with phytochemical inhibitors for combatting dengue virus pathogenicity through in silico analysis
  40. Ultrasound induced biosynthesis of silver nanoparticles embedded into chitosan polymers: Investigation of its anti-cutaneous squamous cell carcinoma effects
  41. Copper oxide nanoparticles-mediated Heliotropium bacciferum leaf extract: Antifungal activity and molecular docking assays against strawberry pathogens
  42. Sprouted wheat flour for improving physical, chemical, rheological, microbial load, and quality properties of fino bread
  43. Comparative toxicity assessment of fisetin-aided artificial intelligence-assisted drug design targeting epibulbar dermoid through phytochemicals
  44. Acute toxicity and anti-inflammatory activity of bis-thiourea derivatives
  45. Anti-diabetic activity-guided isolation of α-amylase and α-glucosidase inhibitory terpenes from Capsella bursa-pastoris Linn.
  46. GC–MS analysis of Lactobacillus plantarum YW11 metabolites and its computational analysis on familial pulmonary fibrosis hub genes
  47. Green formulation of copper nanoparticles by Pistacia khinjuk leaf aqueous extract: Introducing a novel chemotherapeutic drug for the treatment of prostate cancer
  48. Improved photocatalytic properties of WO3 nanoparticles for Malachite green dye degradation under visible light irradiation: An effect of La doping
  49. One-pot synthesis of a network of Mn2O3–MnO2–poly(m-methylaniline) composite nanorods on a polypyrrole film presents a promising and efficient optoelectronic and solar cell device
  50. Groundwater quality and health risk assessment of nitrate and fluoride in Al Qaseem area, Saudi Arabia
  51. A comparative study of the antifungal efficacy and phytochemical composition of date palm leaflet extracts
  52. Processing of alcohol pomelo beverage (Citrus grandis (L.) Osbeck) using saccharomyces yeast: Optimization, physicochemical quality, and sensory characteristics
  53. Specialized compounds of four Cameroonian spices: Isolation, characterization, and in silico evaluation as prospective SARS-CoV-2 inhibitors
  54. Identification of a novel drug target in Porphyromonas gingivalis by a computational genome analysis approach
  55. Physico-chemical properties and durability of a fly-ash-based geopolymer
  56. FMS-like tyrosine kinase 3 inhibitory potentials of some phytochemicals from anti-leukemic plants using computational chemical methodologies
  57. Wild Thymus zygis L. ssp. gracilis and Eucalyptus camaldulensis Dehnh.: Chemical composition, antioxidant and antibacterial activities of essential oils
  58. 3D-QSAR, molecular docking, ADMET, simulation dynamic, and retrosynthesis studies on new styrylquinolines derivatives against breast cancer
  59. Deciphering the influenza neuraminidase inhibitory potential of naturally occurring biflavonoids: An in silico approach
  60. Determination of heavy elements in agricultural regions, Saudi Arabia
  61. Synthesis and characterization of antioxidant-enriched Moringa oil-based edible oleogel
  62. Ameliorative effects of thistle and thyme honeys on cyclophosphamide-induced toxicity in mice
  63. Study of phytochemical compound and antipyretic activity of Chenopodium ambrosioides L. fractions
  64. Investigating the adsorption mechanism of zinc chloride-modified porous carbon for sulfadiazine removal from water
  65. Performance repair of building materials using alumina and silica composite nanomaterials with electrodynamic properties
  66. Effects of nanoparticles on the activity and resistance genes of anaerobic digestion enzymes in livestock and poultry manure containing the antibiotic tetracycline
  67. Effect of copper nanoparticles green-synthesized using Ocimum basilicum against Pseudomonas aeruginosa in mice lung infection model
  68. Cardioprotective effects of nanoparticles green formulated by Spinacia oleracea extract on isoproterenol-induced myocardial infarction in mice by the determination of PPAR-γ/NF-κB pathway
  69. Anti-OTC antibody-conjugated fluorescent magnetic/silica and fluorescent hybrid silica nanoparticles for oxytetracycline detection
  70. Curcumin conjugated zinc nanoparticles for the treatment of myocardial infarction
  71. Identification and in silico screening of natural phloroglucinols as potential PI3Kα inhibitors: A computational approach for drug discovery
  72. Exploring the phytochemical profile and antioxidant evaluation: Molecular docking and ADMET analysis of main compounds from three Solanum species in Saudi Arabia
  73. Unveiling the molecular composition and biological properties of essential oil derived from the leaves of wild Mentha aquatica L.: A comprehensive in vitro and in silico exploration
  74. Analysis of bioactive compounds present in Boerhavia elegans seeds by GC-MS
  75. Homology modeling and molecular docking study of corticotrophin-releasing hormone: An approach to treat stress-related diseases
  76. LncRNA MIR17HG alleviates heart failure via targeting MIR17HG/miR-153-3p/SIRT1 axis in in vitro model
  77. Development and validation of a stability indicating UPLC-DAD method coupled with MS-TQD for ramipril and thymoquinone in bioactive SNEDDS with in silico toxicity analysis of ramipril degradation products
  78. Biosynthesis of Ag/Cu nanocomposite mediated by Curcuma longa: Evaluation of its antibacterial properties against oral pathogens
  79. Development of AMBER-compliant transferable force field parameters for polytetrafluoroethylene
  80. Treatment of gestational diabetes by Acroptilon repens leaf aqueous extract green-formulated iron nanoparticles in rats
  81. Development and characterization of new ecological adsorbents based on cardoon wastes: Application to brilliant green adsorption
  82. A fast, sensitive, greener, and stability-indicating HPLC method for the standardization and quantitative determination of chlorhexidine acetate in commercial products
  83. Assessment of Se, As, Cd, Cr, Hg, and Pb content status in Ankang tea plantations of China
  84. Effect of transition metal chloride (ZnCl2) on low-temperature pyrolysis of high ash bituminous coal
  85. Evaluating polyphenol and ascorbic acid contents, tannin removal ability, and physical properties during hydrolysis and convective hot-air drying of cashew apple powder
  86. Development and characterization of functional low-fat frozen dairy dessert enhanced with dried lemongrass powder
  87. Scrutinizing the effect of additive and synergistic antibiotics against carbapenem-resistant Pseudomonas aeruginosa
  88. Preparation, characterization, and determination of the therapeutic effects of copper nanoparticles green-formulated by Pistacia atlantica in diabetes-induced cardiac dysfunction in rat
  89. Antioxidant and antidiabetic potentials of methoxy-substituted Schiff bases using in vitro, in vivo, and molecular simulation approaches
  90. Anti-melanoma cancer activity and chemical profile of the essential oil of Seseli yunnanense Franch
  91. Molecular docking analysis of subtilisin-like alkaline serine protease (SLASP) and laccase with natural biopolymers
  92. Overcoming methicillin resistance by methicillin-resistant Staphylococcus aureus: Computational evaluation of napthyridine and oxadiazoles compounds for potential dual inhibition of PBP-2a and FemA proteins
  93. Exploring novel antitubercular agents: Innovative design of 2,3-diaryl-quinoxalines targeting DprE1 for effective tuberculosis treatment
  94. Drimia maritima flowers as a source of biologically potent components: Optimization of bioactive compound extractions, isolation, UPLC–ESI–MS/MS, and pharmacological properties
  95. Estimating molecular properties, drug-likeness, cardiotoxic risk, liability profile, and molecular docking study to characterize binding process of key phyto-compounds against serotonin 5-HT2A receptor
  96. Fabrication of β-cyclodextrin-based microgels for enhancing solubility of Terbinafine: An in-vitro and in-vivo toxicological evaluation
  97. Phyto-mediated synthesis of ZnO nanoparticles and their sunlight-driven photocatalytic degradation of cationic and anionic dyes
  98. Monosodium glutamate induces hypothalamic–pituitary–adrenal axis hyperactivation, glucocorticoid receptors down-regulation, and systemic inflammatory response in young male rats: Impact on miR-155 and miR-218
  99. Quality control analyses of selected honey samples from Serbia based on their mineral and flavonoid profiles, and the invertase activity
  100. Eco-friendly synthesis of silver nanoparticles using Phyllanthus niruri leaf extract: Assessment of antimicrobial activity, effectiveness on tropical neglected mosquito vector control, and biocompatibility using a fibroblast cell line model
  101. Green synthesis of silver nanoparticles containing Cichorium intybus to treat the sepsis-induced DNA damage in the liver of Wistar albino rats
  102. Quality changes of durian pulp (Durio ziberhinus Murr.) in cold storage
  103. Study on recrystallization process of nitroguanidine by directly adding cold water to control temperature
  104. Determination of heavy metals and health risk assessment in drinking water in Bukayriyah City, Saudi Arabia
  105. Larvicidal properties of essential oils of three Artemisia species against the chemically insecticide-resistant Nile fever vector Culex pipiens (L.) (Diptera: Culicidae): In vitro and in silico studies
  106. Design, synthesis, characterization, and theoretical calculations, along with in silico and in vitro antimicrobial proprieties of new isoxazole-amide conjugates
  107. The impact of drying and extraction methods on total lipid, fatty acid profile, and cytotoxicity of Tenebrio molitor larvae
  108. A zinc oxide–tin oxide–nerolidol hybrid nanomaterial: Efficacy against esophageal squamous cell carcinoma
  109. Research on technological process for production of muskmelon juice (Cucumis melo L.)
  110. Physicochemical components, antioxidant activity, and predictive models for quality of soursop tea (Annona muricata L.) during heat pump drying
  111. Characterization and application of Fe1−xCoxFe2O4 nanoparticles in Direct Red 79 adsorption
  112. Torilis arvensis ethanolic extract: Phytochemical analysis, antifungal efficacy, and cytotoxicity properties
  113. Magnetite–poly-1H pyrrole dendritic nanocomposite seeded on poly-1H pyrrole: A promising photocathode for green hydrogen generation from sanitation water without using external sacrificing agent
  114. HPLC and GC–MS analyses of phytochemical compounds in Haloxylon salicornicum extract: Antibacterial and antifungal activity assessment of phytopathogens
  115. Efficient and stable to coking catalysts of ethanol steam reforming comprised of Ni + Ru loaded on MgAl2O4 + LnFe0.7Ni0.3O3 (Ln = La, Pr) nanocomposites prepared via cost-effective procedure with Pluronic P123 copolymer
  116. Nitrogen and boron co-doped carbon dots probe for selectively detecting Hg2+ in water samples and the detection mechanism
  117. Heavy metals in road dust from typical old industrial areas of Wuhan: Seasonal distribution and bioaccessibility-based health risk assessment
  118. Phytochemical profiling and bioactivity evaluation of CBD- and THC-enriched Cannabis sativa extracts: In vitro and in silico investigation of antioxidant and anti-inflammatory effects
  119. Investigating dye adsorption: The role of surface-modified montmorillonite nanoclay in kinetics, isotherms, and thermodynamics
  120. Antimicrobial activity, induction of ROS generation in HepG2 liver cancer cells, and chemical composition of Pterospermum heterophyllum
  121. Study on the performance of nanoparticle-modified PVDF membrane in delaying membrane aging
  122. Impact of cholesterol in encapsulated vitamin E acetate within cocoliposomes
  123. Review Articles
  124. Structural aspects of Pt(η3-X1N1X2)(PL) (X1,2 = O, C, or Se) and Pt(η3-N1N2X1)(PL) (X1 = C, S, or Se) derivatives
  125. Biosurfactants in biocorrosion and corrosion mitigation of metals: An overview
  126. Stimulus-responsive MOF–hydrogel composites: Classification, preparation, characterization, and their advancement in medical treatments
  127. Electrochemical dissolution of titanium under alternating current polarization to obtain its dioxide
  128. Special Issue on Recent Trends in Green Chemistry
  129. Phytochemical screening and antioxidant activity of Vitex agnus-castus L.
  130. Phytochemical study, antioxidant activity, and dermoprotective activity of Chenopodium ambrosioides (L.)
  131. Exploitation of mangliculous marine fungi, Amarenographium solium, for the green synthesis of silver nanoparticles and their activity against multiple drug-resistant bacteria
  132. Study of the phytotoxicity of margines on Pistia stratiotes L.
  133. Special Issue on Advanced Nanomaterials for Energy, Environmental and Biological Applications - Part III
  134. Impact of biogenic zinc oxide nanoparticles on growth, development, and antioxidant system of high protein content crop (Lablab purpureus L.) sweet
  135. Green synthesis, characterization, and application of iron and molybdenum nanoparticles and their composites for enhancing the growth of Solanum lycopersicum
  136. Green synthesis of silver nanoparticles from Olea europaea L. extracted polysaccharides, characterization, and its assessment as an antimicrobial agent against multiple pathogenic microbes
  137. Photocatalytic treatment of organic dyes using metal oxides and nanocomposites: A quantitative study
  138. Antifungal, antioxidant, and photocatalytic activities of greenly synthesized iron oxide nanoparticles
  139. Special Issue on Phytochemical and Pharmacological Scrutinization of Medicinal Plants
  140. Hepatoprotective effects of safranal on acetaminophen-induced hepatotoxicity in rats
  141. Chemical composition and biological properties of Thymus capitatus plants from Algerian high plains: A comparative and analytical study
  142. Chemical composition and bioactivities of the methanol root extracts of Saussurea costus
  143. In vivo protective effects of vitamin C against cyto-genotoxicity induced by Dysphania ambrosioides aqueous extract
  144. Insights about the deleterious impact of a carbamate pesticide on some metabolic immune and antioxidant functions and a focus on the protective ability of a Saharan shrub and its anti-edematous property
  145. A comprehensive review uncovering the anticancerous potential of genkwanin (plant-derived compound) in several human carcinomas
  146. A study to investigate the anticancer potential of carvacrol via targeting Notch signaling in breast cancer
  147. Assessment of anti-diabetic properties of Ziziphus oenopolia (L.) wild edible fruit extract: In vitro and in silico investigations through molecular docking analysis
  148. Optimization of polyphenol extraction, phenolic profile by LC-ESI-MS/MS, antioxidant, anti-enzymatic, and cytotoxic activities of Physalis acutifolia
  149. Phytochemical screening, antioxidant properties, and photo-protective activities of Salvia balansae de Noé ex Coss
  150. Antihyperglycemic, antiglycation, anti-hypercholesteremic, and toxicity evaluation with gas chromatography mass spectrometry profiling for Aloe armatissima leaves
  151. Phyto-fabrication and characterization of gold nanoparticles by using Timur (Zanthoxylum armatum DC) and their effect on wound healing
  152. Does Erodium trifolium (Cav.) Guitt exhibit medicinal properties? Response elements from phytochemical profiling, enzyme-inhibiting, and antioxidant and antimicrobial activities
  153. Integrative in silico evaluation of the antiviral potential of terpenoids and its metal complexes derived from Homalomena aromatica based on main protease of SARS-CoV-2
  154. 6-Methoxyflavone improves anxiety, depression, and memory by increasing monoamines in mice brain: HPLC analysis and in silico studies
  155. Simultaneous extraction and quantification of hydrophilic and lipophilic antioxidants in Solanum lycopersicum L. varieties marketed in Saudi Arabia
  156. Biological evaluation of CH3OH and C2H5OH of Berberis vulgaris for in vivo antileishmanial potential against Leishmania tropica in murine models
Jetzt anmelden und 20% sparen
Institutioneller Zugang
Wie funktioniert Authentifizierung?
Haben Sie eine Idee, wie wir unsere Website verbessern können?
Bitte schreiben Sie uns.
© 2025 De Gruyter Brill
Heruntergeladen am 6.12.2025 von https://www.degruyterbrill.com/document/doi/10.1515/chem-2024-0083/html
Button zum nach oben scrollen